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STATEMENT OF ISSUE PRESENTED FOR REVIEW 
1. Was the Industrial Commission correct in concluding that 
the decedentfs death was the result of an injury by accident 
arising out of or during the course of his employment; or was 
decedent's death the result of a non-compensable heart attack that 
occurred as the result of an underlying heart condition and not 
because of his employment? 
More specifically, the issue may be stated as follows: Was 
there substantial competent evidence in the record to warrant a 
finding of both legal causation and medical causation linking 
decedent1s death with activities of his employment? 
DETERMINATIVE STATUTES 
Section 35-1-45 COMPENSATION FOR INDUSTRIAL ACCIDENTS TO BE 
PAID 
Section 35-1-77 MEDICAL PANEL-DISCRETIONARY AUTHORITY OF 
COMMISSION TO REFER CASE - FINDINGS AND 
REPORTS - OBJECTIONS TO REPORT HEARING 
EXPENSES 
Section 35-1-82.54 REVIEW OF CASES AND ORDERS BY COMMISSION-
PROCEDURES - EFFECT OF AWARD 
Section 35-1-83 REVIEW BY COURT OF APPEALS 
WORKERS' COMPENSATION RULES & REGULATIONS, RULE 1.2.33 
(See Appendix I for Text of Statutes) 
STATEMENT OF THE CASE 
A. Nature of the Case, Course of Proceedings, and 
Disposition by the Industrial Commission. 
This case arises under the Utah Workers' Compensation Act, 
and the Utah Court of Appeals has jurisdiction over this matter 
pursuant to §78-2a-3, Utah Code Annotated (1953, as amended). 
The applicant, Bernice Steward, widow of Dale W. Steward, filed a 
Claim for Dependent's Benefits and/or Burial Benefits on February 
17, 1986. (R 2). An evidentiary hearing was held on November 5, 
1986 (R 19). On May 28, 1987 an Order was entered by 
Administrative Law Judge Richard G. Sumsion entitling Bernice 
Steward to dependent's benefits. (R 268) Said Order was based 
upon a finding by the Administrative Law Judge that the applicant 
had met her burden of proof in establishing both legal and medical 
causation and that the decedent's death was precipitated by the 
conditions of his employment. 
On June 12, 1987 appellants - Workers" Compensation Fund of 
Utah moved for review of the order. (R 276) The Industrial 
Commission denied the Motion for Review, and adopted the Findings 
of Fact and Conclusions of Law of the Administrative Law Judge. 
(R 286) (See orders attached as Appendices II and III). 
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B. STATEMENT OF FACTS 
1. On November 11, 1985 Dale W. Steward
 f the decedent, was 
employed as a truck driver for Lanier Brugh Corporation. Lanier 
Brugh is a contract carrier with the United States Postal Service 
for delivery of mail between various locations. (R 30-32) 
2. Mr. Stewards job entailed driving a truck between Salt 
Lake City and Denver. On November 11, 1985 Steward departed from 
Salt Lake City at approximately 5:30 A.M. (R 27, 31) 
3# Mr. Steward drove through a snow storm on the way to 
Denver, and arrived at approximately 5:30 P.M. on November 11, 
1985. (R 44, 49) 
4. Mr. Steward commenced his return trip to Salt Lake City 
at approximately 11:15 P.M. on November 11, 1985. (R 86) 
5. Approximately fifteen to thirty minutes after Mr. 
Steward had departed Denver for Salt lake City, his truck was 
observed moving over two lanes of traffic to his left. The truck 
then hit the median and lodged on top of it. (R 104) The 
accident report indicates that Mr. Steward died of a heart attack 
prior to the truck coming to rest on the median. (R 99) 
6. Mr. Steward's body was transported to Humana Hospital 
where it was determined that the cause of death was "apparent 
acute myocardial infarction." (R 3) 
7. At the time of the accident the road was dry and there 
were no adverse weather conditions. (R 99-100) 
8. At the time of the accident, Mr. Steward had been taking 
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dexedrine or dextroamphetamine because he suffered from 
narcolepsy. (R 38, 46, 111-112) 
9. At the date of his death, decedent was 56 years old. (R 
55) 
10. Mr. Steward had a 36 year smoking history in which he 
would smoke approximately one and one half packs of cigarettes a 
day. (R 55) 
11. Mr. Steward was diagnosed as having emphysema. (R 55, 
125) 
12. Mr. Steward was, at the time of his death, approximately 
five feet nine inches tall, and about 200 pounds. 
SUMMARY OF ARGUMENT 
Section 35-1-45, Utah Code Annotated (1953, as amended) 
provides for an award of benefits to the dependents of an employee 
who is killed "by accident arising out of or in the course of his 
employment . . . . " In order for such an accident to be 
compensable, the claimant must show that the decedents employment 
was both the legal cause and the medical cause of his death. 
Because decedent had several risk factors for heart disease 
(a pre-existing condition), to show legal causation the claimant 
must prove that decedent put forth unusual or extraordinary 
exertion in carrying out his employment duties. Inasmuch as 
decedent did not put forth any such unusual exertion, decedent's 
employment did not contribute anything substantial to increase the 
risk he already faced in non-employment life. Accordingly, 
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decedentfs employment was not the legal cause of his death, and 
the claim is not compensable. 
The Industrial Commission also erred in concluding that 
decedents death was medically caused by his employment. There is 
no competent evidence in the record to support a finding of a 
medically demonstrable causal link between any work related 
exertion and decedents death. Therefore, the Commission's 
findings regarding this issue are arbitrary and capricious, and 
subject to reversal. 
Further, in determining that medical causation existed, the 
Administrative Law Judge improperly took judicial notice of, and 
relied upon medical literature which was not introduced into 
evidence at the hearing thereby precluding defendants from 
providing countering evidence and authority. The administrative 
law judge also failed to refer the case to a medical panel 
contrary to the Commission's own rules. (See Workers' 
Compensation Rules and Regulations attached as Appendix IV.) The 
Commission failed to review all of the evidence and record as the 
transcript of the hearing was not prepared until after the 
Petition for Writ of Review was served. 
ARGUMENT 
POINT I 
IN ACCORDANCE WITH THE "ALLEN TEST," BECAUSE THE 
DECEDENT HAD A PRE-EXISTING CONDITION WHICH CONTRIBUTED 
TO HIS INJURY, AND HE DID NOT PUT FORTH UNUSUAL OR 
EXTRAORDINARY EXERTION, DECEDENT'S EMPLOYMENT WAS NOT 
THE LEGAL CAUSE OF HIS DEATH, AND THEREFORE THE ACCIDENT 
IS NOT COMPENSABLE. 
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Section 35-1-45, Utah Code Annotated (1953, as amended) 
provides for an award of benefits to the dependents of an 
employee who is killed "by [an] accident arising out of or in the 
course of his employment. . . . " While the Workers' Compensation 
Act does not define this phrase, the recent case of Allen v. 
Industrial Commission, 729 P2d 15 (Utah 1986) sets forth the 
analysis to be followed in accident cases involving internal 
failures. In Allen, the sole issue on appeal was whether the 
claimant who had suffered pre-existing back problems and was 
injured as the result of exertion usual and typical for his job, 
was injured "by accident arising out of or in the course of 
employment." In addressing this issue, the Utah Supreme Court set 
forth as follows: 
This statute creates two prerequisites for a 
finding of a compensable injury. First, the 
injury must be "by accident." Second, the 
language "arising out of or in the course of 
employment" requires that there be a causal 
connection between the injury and the 
employment. 
* * * 
The language "arising out of or in the course 
of his employment" found in U.C.A., 1953, 
Section 35-1-45 (Supp. 1986), was apparently 
intended to ensure that compensation is only 
awarded where there is a sufficient causal 
connection between the disability and the 
working conditions. The causation requirement 
makes it necessary to distinguish those 
injuries which (a) coincidentally occur at 
work because a preexisting condition results 
in symptoms which appear during work hours 
without any enhancement from the work place, 
and (b) those injuries which occur because 
some condition or exertion required by the 
employment increases the risk of injury which 
the worker normally faces in his everyday 
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l i f e . See Bryant v . Masters Machine Co , , 44 
A.2d 329, 337 (Me. 1982) . Only the l a t t e r type 
of i n j u r y i s compensable under U.C.A., 1953, 
Sect ion 35 -1 -45 . There i s no f ixed formula by 
which the causat ion i s sue may be re so lved , and 
the i s s u e must be determined on the f a c t s of 
each c a s e . 
P r o f e s s o r Larson has s u g g e s t e d a t w o - p a r t 
c a u s a t i o n t e s t which i s c o n s i s t e n t with the 
purpose of our workers1 compensation laws and 
h e l p f u l i n d e t e r m i n i n g c a u s a t i o n . We 
t h e r e f o r e adopt t h a t t e s t . Larson sugges t s 
t h a t c o m p e n s a b l e i n j u r i e s can b e s t be 
i d e n t i f i e d by f i r s t c o n s i d e r i n g the l e g a l 
c a u s e of t h e i n j u r y and then i t s medica l 
cause . Larson, supra Sect ion 38.83 ( a ) , at 
7 - 2 7 3 . "Under the l e g a l t e s t , the law must 
d e f i n e what kind of e x e r t i o n s a t i s f i e s the 
t e s t o f ' a r i s i n g o u t o f t h e 
e m p l o y m e n t f . . . [ t h e n ] the d o c t o r s must say 
whether the exer t ion (having been held l e g a l l y 
s u f f i c i e n t t o support compensation) in fac t 
caused t h i s [ i n j u r y ] . " Larson, supra Sect ion 
38.83 ( a ) , at -276 to -277 . 
1 . Legal Cause - Whether an injury arose out 
of or in the course of employment i s d i f f i c u l t 
to determine where the employee brings to the 
work place a personal element of risk such as 
p r e e x i s t i n g cond i t ion . 
* * * 
To meet the l e g a l c a u s a t i o n requirement , a 
c l a i m a n t wi th a p r e e x i s t i n g c o n d i t i o n must 
show that the employment contributed something 
s u b s t a n t i a l t o i n c r e a s e the risk he already 
f a c e d i n e v e r y d a y l i f e b e c a u s e of h i s 
cond i t i on . This addi t ional element of risk in 
t h e work p l a c e i s u s u a l l y s u p p l i e d by an 
e x e r t i o n g r e a t e r t h a n t h a t undertaken in 
normal , everyday l i f e . This extra exer t ion 
serves to o f f s e t the p r e e x i s t i n g condi t ion of 
the employee as a l i k e l y cause of the injury 
t h e r e b y e l i m i n a t i n g c l a i m s for impairments 
r e s u l t i n g from a p e r s o n a l r i s k rather than 
e x e r t i o n s a t work. Larson , sjmua/ Sec t ion 
3 8 . 8 3 (b) , a t 2 - 2 7 8 . Larson summarized how 
the l e g a l cause rule would work in prac t i ce as 
f o l l o w s : 
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If there is some personal causal contribution 
in the form of a [preexisting condition], the 
employment contribution must take the form of 
an exertion greater than that of nonemployment 
life.... 
If there is no personal causal contribution 
that is, if there is no prior weakness or 
disease, any exertion connected with the 
employment and causally connected with the 
[injury] as a matter of medical fact is 
adequate to satisfy the legal test of 
causation. 
Id. Thus, where the claimant suffers from a 
preexisting condition which contributes to the 
injury, an unusual or extraordinary exertion 
is required to prove legal causation. Where 
there is no preexisting condition, a usual or 
ordinary exertion is sufficient. 
729 P2d at 18, 24-26 
Regarding the legal causation requirement, it is appellant's 
contention that the Administrative Law Judge misapplied the Allen 
legal causation standard. In his Findings of Fact, Conclusions of 
Law, and Order, the Administrative Law Judge used the lower 
standard of the Allen test which assumes that usual or ordinary 
exertion is sufficient to show legal causation when there is no 
pre-existing condition. 
The Judge stated, "In Mr. Steward's case, there is no 
evidence of any previously diagnosed heart condition.11 (R. 270) 
Appellant's take exception to the utilization of this lower 
legal causation standard, and contend that inasmuch as the 
decedent had several risk factors for heart disease, the higher 
standard of causation as outlined in Allen was the appropriate 
test to use. The risk factors included a 36 year smoking habit in 
which decedent smoked one and one-half packs of cigarettes a day, 
high levels of amphetamine use prescribed for narcolepsy, 
emphysema, and obesity. (R.55, 94, 125) In addition, decedent at 
the time of his death, was 56 years of age. Further, prior to his 
death, the decedent had demonstrated other suspicious symptoms of 
heart problems. In fact, Dr. M. Peter Heilbrun indicated on 
November 18, 1985 that, "In retrospect, it makes me wonder if some 
of [Dale Steward's] recent neck and shoulder pain was possibly 
myocardial in origin." (R. 135) 
It should also be noted that the pre-existing condition of 
which Allen speaks need not be patent nor "previously diagnosed." 
See Justice Zimmerman's concurring opinion in Holloway v. 
Industrial Commission. 729 P2d 31, 32 (Utah 1986) wherein it was 
stated: 
With respect to the focus of t h i s case on 
remand-whether Holloway had a p reex i s t ing 
condition-I would observe that the preexisting 
condit ion of which Allen speaks need not be 
patent; in fact , i t need not have been known 
or knowable to anyone before the injury. The 
sole quest ion i s whether the worker came to 
the work place with a condition that increased 
h i s r i s k of i n j u r y . If he did and tha t 
cond i t i on contr ibuted to the in ju ry , then 
Allen 1s higher standard of l ega l causation 
comes into play so as to place that worker on 
the same footing as one who did not come to 
work with a preexisting condition. 
I t i s appe l lan t s contention that the decedent came to the 
workplace with p r e - e x i s t i n g c o n d i t i o n s (heart d isease and 
narcolepsy t r ea t ed by amphetamines),. Therefore, before legal 
causat ion can be es tab l i shed there must be a finding that the 
employment ac t iv i t i e s of decedent involved exertion in excess of 
the normally expected level of nonemployment ac t iv i ty . Decedent 
was diagnosed as having narcolepsy and he had a predisposition to 
fatal arrhythmia due to his amphetamine consumption to treat his 
narcolepsy. (R 111 and 288 paragraphs 4 & 5) That is, decedent 
at the time of his death, was taking dexedrine and ritalin for 
treatment of his narcolepsy. (R 130, 132r 133). The use of these 
prescribed drugs makes one more susceptible to suffering a fatal 
arrhythmia. (See Physician's Desk Reference attached as Appendix 
V) . Accordingly, because decedent was predisposed to suffering a 
fatal arrhythmia, he had a pre-existing condition. The higher 
standard requiring unusual exertion should have been utilized. 
In the Order Denying Motion for Review, the Industrial 
Commission states that even if the unusual exertion standard was 
applied, the facts relate exertion and/or stress that goes beyond 
what the average person encounters in everyday nonemployment life; 
specifically, that decedent had to drive on snow covered roads, he 
had little rest in between the trip to Denver and the return trip 
to Salt Lake City, and that decedent had been taking amphetamines. 
(R. 287). Appellants refute this contention and maintain that the 
facts do not support a finding that decedent put forth an exertion 
greater than that of nonemployment life. 
In this case the decedent had not undergone any unusual or 
extraordinary exertion in the time frame immediately preceding his 
fatal heart attack. At the time of his heart attack, the decedent 
was just outside of Denver, Colorado. (R 86). The road 
conditions were clear and dry. (R 99-100. See also photographs of 
accident scene at R 101). Further, decedent had been driving only 
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15 to 30 minutes on his return trip to Salt Lake City after a five 
hour and forty-five minute layover in Denver when he suffered the 
heart attack. (R 44, 49, 86) 
Decedent's employment did not contribute anything substantial 
to increase the risk he already faced in everyday life. Rather, 
the heart attack coincidentally occurred during work hours 
without any enhancement from the work place or conditions 
surrounding his work place. Accordingly, because decedents heart 
attack was not legally caused by his employment, the "accident" 
herein did not "arise out of or in the course of employment," and 
is therefore not compensable. 
Moreover, because the Commission's findings are not supported 
by the facts in the record, the finding is arbitrary and 
capricious and subject to reversal. Kaiser Steel Corporation v. 
Monfredi. 631 P.2d 888 (Utah 1981). For other recent Utah cases 
which are consistent with Allen, and supportive of appellants 
position, see the following: Holloway v. Industrial Commission. 
729 P.2d 31 (Utah 1986); Price River Coal v. Industrial 
Commission/ 731 P.2d 1080 (Utah, 1981); Hone v. J.F. Shea Company. 
728 P.2d 1008 (Utah, 1986). 
POINT II 
THE INDUSTRIAL COMMISSION ERRED IN CONCLUDING 
THAT THERE WAS SUFFICIENT EVIDENCE TO SUPPORT 
A FINDING THAT THE STRESS OR EXERTION REQUIRED 
BY DECEDENT'S JOB WAS THE MEDICAL CAUSE OF HIS 
DEATH. 
ACCORDINGLY, BECAUSE THERE IS NO MEDICALLY 
DEMONSTABLE CAUSAL LINK BETWEEN THE WORK-
RELATED EXERTIONS AND THE DEATH, THE ACCIDENT 
IS NOT COMPENSABLE. 
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The Industrial Commission concluded that there was a 
medically demonstrable causal link between decedent's work-related 
exertions and his death. Inasmuch as this conclusion is not 
supported by substantial medical evidence, appellant asserts that 
the finding of medical causation is arbitrary and capricious. 
As with the issue of legal causation, Allen is an appropriate 
place to begin a discussion concerning medical causation. The 
Utah Supreme Court set forth the following: 
[10] 2. Medical Cause-The second par t of 
Larson's dual-causation t es t requires that the 
claimant prove the d i sab i l i ty i s medically the 
resul t of an exertion or injury that occurred 
during a work-related ac t iv i ty . The purpose 
of the medical cause t es t i s to ensure that 
there i s a medically demonstrable causal link 
between the work re l a t ed exer t ions and the 
unexpected injuries that resulted from those 
s t r a i n s . The medical causal requirement will 
prevent an employer from becoming a general 
i n s u r e r of h i s employees and d i scourage 
fraudulent claims. With the issue being one 
primarily of causation, the importance of the 
medical panel becomes manifest. I t i s through 
the expe r t i s e of the medical panel that the 
Commission s h o u l d be ab le to make the 
determination of whether the injury sustained 
by a c l a iman t i s c a u s a l l y connected or 
contributed to by the claimant's employment. 
Schmid t , 617 P.2d a t 697 (Wi lk in s , J . , 
concur r ing) . Under the medical cause t e s t , 
the claimant must show by evidence, opinion, 
or o t h e r w i s e that: the s t r e s s , s t r a i n , or 
exer t ion required by his or her occupation 
led to the result ing injury or d i s ab i l i t y . In 
the event the claimant cannot show a medical 
c a u s a l connect ion, compensation should be 
denied. (Emphasis added) 
729 P.2d at 27. 
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Thus, in accordance w.r.i . i^ i i ^ 
be compensable, .* - , * d e t e r m i n e o t t :a t wie- . i : 
nied J e\;i 1 I » I. ii * s i u i u , KJL c x e r i i o n r equ i r ed ^ 
ones employment. 
In the proceedings below, the Administrative Law Judge he ld-
and the Indui xau medical causat ion was 
e s t a b l i s h e d because the e x t r a s t r e s s the decedent faced dur ing the 
;M hour s |»f eced i, n>:.j hi i o death most l i k e l y l ed to the arrhythmia 
which resu l ted in the ta ta l heart at l a r k . 
rl iie e x t: r a s t r e s s f a c t o r s c i t e d by t he Admi n i s t r a t i ve Law 
iJudije i in: I Uilo«'l i 
1. Anxiety caused by the late arrival uf iletcdt ml, „ I im k 
thoreby delaying : :. • departure from Salt Lake City. 
.'"' I'"".it i I.)UI < \ [Odos and 
during a snow storm, bott .-« a : • . Denver. 
I « J >m inadequate rest prior to his departure" f:rom 
Denver, 
i imphetamines, obably ' greater imounts 
than usu.: * let^t. \s\. *-
H; should be noteu ai 'int IJ 4 u ^ that +-wn above 
referenced stress factor - * < :p:<orte* ^ record 
i mi I h i s Ctioi, . ,o[Jt-i i eviuer 
record that the decedent was : ,v .iippery roac 
y^r. Road conditions a' tip rime of t;*.r: decedent 
r ecu in ti,- from Denver V ^ P . a 
Also, the decedent's use o: mphetamines was - ,iiu- , .^->-
' 13 
adequate rest." Rather, the decedent had a long-standing 
condition of narcolepsy which was treated through prescription use 
of high doses of amphetamines. The Judge's statement that the use 
of amphetamines was increased due to the decedent's level of 
fatigue as a result of his truck driving just prior to the time of 
his heart attack was not argued at the hearing and assumes facts 
not supported by the record. It is appellants' belief that the 
record is void of any substantial evidence which would support a 
finding of medical causation. 
In concluding that the medical causation standard was met, 
the Administrative Law Judge quoted and adopted the entire report 
of Dr. Perry. (R 270-272) Interestingly, Dr. Perry indicated 
that the decedent's heart attack was idiopathic. (R 111-112). 
However, the Administrative Law Judge found that the four factors 
outlined above precipitated the decedent's fatal heart attack. 
Appellant's aver that the Administrative Law Judge's opinion 
that the noted factors were the medical cause of the decedent's 
heart attack oversteps the bounds of a fact finder and a judge 
charged to rule in matters of law. A lay person is not qualified 
to propound medical opinion. In this matter, the Administrative 
Law Judge was not weighing and choosing between competing medical 
opinions in the record. The judge, though stating he relied on 
the report of Dr. Perry, in reality disregarded the key points. 
I think trauma can be excluded with a 
reasonable degree of confidence in this 
case . . . 
* * * * 
14 
In terms of medical p robab i l i t y i t i s most 
l i k e l y tha t he experienced a f a t a l cardiac 
arrhythmia while driving, lost consciousness a 
few seconds la te r thus losing control of the 
vehic le and having the accident as reported. 
I t is possible that his dextroamphetamine was 
re l a t ed to his death because i t may worsen 
arrhythmias in (sic) suseptible individuals. 
An autopsy would have been supporting th is 
diagnosis, but l ikely would not have confirmed 
i t with an absolute degree of cer ta inty . 1 
suspec t i t would ave shown amphetamines 
present and coronary artery disease present. 
At th is point in time (sic) exuming the body 
would not shed any l ight on the presence of 
amphetamine. I t would, however, document the 
p r e s e n c e or absence of coronary a r t e r y 
d i s e a s e . In the absence of drugs i t i s 
extremely unusual for cardiac arres t to occur 
in a pe r son with normal coronary 
arteries 
* 
In summary in terms of reasonable medical 
probability, the patient suffered a fatal 
arrhythmia while driving and the accident was 
simply the result of his death and subsequent 
loss of control of the vehicle. While other 
possibilities exist, they are far less likely. • 
To (sic) exume and perform a post-mortum 
examination of the body would later those 
probabilities to an extent, but it is highly 
unlikely it wr;~d provide definite answer. 
(R 110 and J.JLJ. ent. . *• r-poic attached hereto 
as Appendix V hereto 
Instead 01 fo).lowing ronsidered opinior - • ,a^. 
rendered his own medical opinion and this i^ *-*< 
The medical causation standard was further discussed ' ,-~ 
n
 °
 n
 t *z , n l i msL£L&L£JL V...L G i l b e r t 
Development, / ift P,' ii :. \ / (ut ah I 4J<; There , the Utah Supreme 
1
 '«ii i4, J|iitil I lii J. Joseph Perry, the same cardiologist involved 
i i i the present case. The Supreme C'oui'ii' noted: 
] 5 
Dr. Perry, the chairman of the medical panel 
and a c a r d i o l o g i s t , t e s t i f i e d t ha t i t was 
"likely1 1 that the conditions under which Mr. 
Lancas ter was working aggravated his p r e -
exist ing heart condition. However, Dr. Perry 
a l so was l e s s than certain about the causal 
connection between the work conditions and the 
myocardial infarct ion. In his report to the 
Administrative Law Judge, Dr. Perry identif ied 
and ranked the role of various risk factors , 
i n c l u d i n g those a s s o c i a t e d with work, in 
p r e c i p i t a t i n g the c l a i m a n t ' s myocard ia l 
infarct ion. . . . . When asked to quantify the 
contribution of pre-existing risk factors and 
work f ac to r s to the c l a iman t ' s myocardial 
infarc t ion , Dr. Perry assigned a value of 90 
p e r c e n t to p r e - e x i s t i n g condi t ions and 10 
p e r c e n t to work c o n d i t i o n s . Dr. Per ry 
explained, however, that his assessment of the 
factors was "a fa i r ly random guess." 
736 P2d at 240. 
Dr. Perry undertook the same type of analysis in this case as 
he did in Lancaster. He briefly discussed several possible, but 
not entirely probable, medical causes of decedent's heart attack. 
Then, Dr. Perry concluded that the heart attack was idiopathic in 
origin and not in all probability, caused by the alleged 
industrial events. 
In Lancaster. the Utah Supreme Court further stated: 
Thus, although there may have been some 
connection between the heart attack and the 
cold weather and high altitude [the industrial 
factors], the evidence of any such connection 
is inconclusive. Not one of the doctors was 
willing to state with medical certainty that 
the claimant's injury was caused by work-
related factors. Thus, there is competent and 
comprehensive medical evidence in the record 
upon which the Administrative Law Judge could 
rely in concluding that medical causation was 
lacking. Although the medical evidence was 
conflicting, it is the responsibility of the 
16 
A d m i n i s t r a t: i v e I • „ i w . I1 u * I q a I, in,. I v e f j c t u d I 
conflicts. 
7 
In the case ar bar, theie is nn competent evidence w^'ch 
shows . ii»• i' i.•.i I c u.i" .1 I I \\> l.elween the alleged industria; •? i--i£ 
and the decedent' s hear t: attack . The on 1 y e v idenc;e 
c 1 a imant cou 1 d p rov i de was the e x £M I st; t, acto statement o * ; 
Heiibrun that because I In- III.I'MII hi , 
[H]ad no prior history of cardiac disease, 
..•his death should be considered to be an 
industrial-related cardiac event. (R. 245) 
It is noteworthy that this lettiet of 1 i H<-MII:U jppeais t.o 
be a tatemei * repared at the widow's request and suggestion. In 
this ±Ight - •. ietter to the claimant 
che same date, July *J, 1986, and stated, 
x am enclosing the following letter. Please read 
through i I and advise me if you feel it satisfactorily 
explains my thoughts on the industrially related nature 
of Dales heart attack. (R 244^ 
E u t t l i e t , D r , i l t M l b i u n i • - r 
a p p e a r s t o c o n t r a d i c t hiu prior statement i November 985 
whert I,, , n,si u J a i . I II I I In - •* shoulder pain 
j u s t prior to h is dea th was "possibly m y o c a r c : 
(R. 135) The foundation for Or", He: ' u-un - vi^w ^t causat ic^ \~ 
l a c k i n g b e c a u s it i eatmer t *.* 
amphetamines makes one more s u s c e p t i b l e > the a r rhy thmias t h a t 
i W a r ( 3 » s l i f e . xo^c P h y s i c i a n s Desk R e f e r e n c e a t 
Appendix 
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Moreover, to substantiate his conclusion, at least in part, 
the Administrative Law Judge discussed certain copyrighted medical 
literature which was not fully quoted, (R 272) Apparently, none 
of the physicians in this case used or relied upon this 
literature. However, the Administrative Law Judge consulted the 
same for his own reference during his decision-making process. 
Appellants contend that such literature cannot be used in ruling 
on this matter. Appellants contention is supported by the 
following line of case law. 
Spencer v. Industrial Commission. 20 P2d 618 (Utah 1933) 
contains language which is supportive of appellant's point of 
view. 
We recognize t h a t the I n d u s t r i a l Commission i s 
not a c o u r t and i s not bound by the usua l 
common law or s t a t u t o r y ru les of evidence or 
by t h e t e c h n i c a l o r f o r m a l r u l e s of 
p r o c e d u r e . . . Y e t , i t i s fundamental t h a t in 
i n v e s t i g a t i o n s s u c h a s t h e I n d u s t r i a l 
Commission i s authorized to make, any par ty to 
a c a u s e or p r o c e e d i n g i s e n t i t l e d to be 
advised of and afforded an opportunity to meet 
such evidence as the commission may consider 
and re ly on in the making of i t ' s f indings and 
d e c i s i o n . Unless such ev idence i s brought 
i n to the case , and in some lawful manner made 
a pa r t of the record, i t cannot be regarded as 
competent e v i d e n c e , and must be excluded in 
determining the suff ic iency of the evidence to 
s u p p o r t t h e f i n d i n g s of t h e I n d u s t r i a l 
Commission. 
20 P2d a t 620 
In the case at bar, certain copyrighted medical literature 
which was not presented at the hearing was considered and relied 
upon in determining that medical causation was established. In 
18 
accordance with Spencer, this medical liieidliuie is uol competent 
evidence and should not have been considered* 
The Wu't kp i' c • Compensation Fund war entitled to be advised of 
and afforded opportunity to meet cii'ul t^ful* at\\ evidence - :h 
the Administrative Law Judge considered and relied upon in making 
his decibi'jii. 
If appellant had been afforded such an opportunity. 
have ;i nt i oduced evidence substantiat i:u , >; ^  , r.tent ion tr.at 
because decedent was , . 
^rcoleptic condit„< predisposed suffer ..; . 
lyment was n ^ - - ra\ -^  * decedents 
death Physicians Desk Reference - i 
Because the Fund was not afforded this fundamental riyht, 
reversib 
See also Ocean Accident & Guarantee Corporation v. Industrial 
Commissi on ."'45 P. 343f 345-346 (1926) wherein the Court stated as 
follows: 
The Legislature, has,, however, by express 
provision (Comp. Laws Utah 1917, Section 3149) 
stated that the Industrial Commission is not 
bound by the usual common or statutory rules 
of evidence or by any technical or formal 
rules of procedure. The commission is given 
the power to adopt its own rules of procedure. 
Rules promulgated by the commission must not, 
of course, deprive the parties of their 
constitutional right of having their day in 
court and of having the cause determined after 
an impartial hearing. 
• J • * * 
D o u b t l e s s the members or tr ie i n d u c t l i a l 
Commission or o ther f a c t f i n d i n g body not 
l imi ted by the ordinary rules re l a t ing to the 
19 
i n t r o d u c t i o n of t e s t imony a re a t t imes jus t i f i ed in adopting "short cuts" to get at 
t h e u l t i m a t e f a c t s in a m a t t e r under 
cons ide ra t ion . But in adopting those short 
cuts or new rules for determining facts care 
should be exercised not to deprive any party 
of every fair means of e l i c i t i ng the facts to 
be f inal ly determined or not to unnecessarily 
l i m i t cross-examination of witnesses before 
i t . 
I t i s a p p e l l a n t s ' contention that in the case at bar, the 
A d m i n i s t r a t i v e Law Judge improperly took a "short cut" by 
considering evidence which appellant had no opportunity to refute. 
This "short cut" had the net effect of depriving appellant of i t s 
const i tut ional right of having i t s day in court and of having the 
cause determined after an impartial hearing. 
See a l s o T i n t i c Standard Mining Company v. I n d u s t r i a l 
Commission, 110 P2d 367, 369 (Utah 1941) wherein the Court set 
forth: 
[T]he Commission should not receive evidence on disputed 
matters where a hearing is held after the hearing is 
closed, since the party adversely affected would have no 
opportunity to meet such evidence... 
Another case which is highly supportive of the Fundfs 
position is Prestige Homes. Inc. v. Legouffe, 658 P.2d 850 (Colo. 
1983). Legouffe was concerned with a workmen's compensation claim 
which was filed by an employee who was seeking recovery for 
permanent disability suffered as the result of a heart attack 
allegedly precipitated by an industrial accident. The expert 
testimony at the hearings on the issue of causation was in 
conflict. The Industrial Commission denied claimant any benefits, 
affirming a finding that claimant had not established a causal 
20 
connection between +^& K* 
appealed/ and the Colorado .ppeal~~ teier ;^ <\ 
C o HI in L s a i o 11 * i t ^ Lht= o r 'i^ * , *• • -
Appeals took judicial notice - certain snier-
found in medica ceatises and concluded that one f *-^-:4 h 
testimony was based ,-~~:- ., r 
and therefore ouild "u* - * J. . basis . ;i concluding tha 
i-c . " lad been shown. 
h Colorado Supreme < . dimJ dddicnsed 
-he issue judicia notice. The C n ^ t concluded that the Court 
,t.yr:.... -u because of its erroneous 
application of tb<* judicial notice rule. 
The C V U L I w^ Appeals relied on medical 
t r e a t i s e s not offered or admitted into 
evidence^ and not cited by either Dr. Lissauer 
or Dr. MutZ/ for its finding that an electric 
shock caused by contact with a 220 volt power 
line can cause serious injury without leaving 
a visible burn mark. The Court in effect 
assumed the role of an expert medical witness 
by discrediting the opinion of Dr. Mutz based 
on independent research and interpretation of 
m e d i c a l texts which p r o p e r l y should be 
interpreted only by experts in the appropriate 
field. See Savers v. Gardner, 380 F.2d 940 
(6th Cir. 1967); Ross v. Gardner, 365 P.2d 554 
(6th Cir, ]966). To accept the court's 
substitution of its own fact findings for 
those of the referee in this instance would 
expand the judicial notice rule far beyond its 
intended scope. 
658 P.2d at a 
« c o n c e r n i n g ] u d i c i a x POT . ^ , a s set: f or t h i i i 
Legouf f e,, i s a p p l i c a b l e t o t h e r a sp By inlyiritj upon 
c e r t a i n medical l i t e r a t u r e which was : )t introduced as ev idence at 
21 
the hearings, the Administrative Law Judge usurped the role of an 
expert medical witness by undertaking independent research and 
interpreting a medical text which he was not properly qualified to 
interpret. Accordingly/ because it was improper for the 
Administrative Law Judge to take such judicial notice, and because 
the notice improperly taken was used to substantiate a finding of 
medical causation, such a finding of medical causation cannot 
stand. 
POINT III 
THE MEDICAL CAUSATION ISSUE SHOULD PROPERLY BE REFERRED 
TO A MEDICAL PANEL. 
As noted in POINT II above, appellants contend that there is 
insufficient competent evidence in the record to support a finding 
of medical causation and therefore a reversal is warranted. In 
the alternative, appellants seek a referral of the medical 
causation issue to a medical panel. To do this, the 
Administrative Law Judge could pose the four risk factors noted by 
him, and ask an appropriate specialist(s) to discuss those factors 
in terms of reasonable medical probability. By doing this, the 
Commission would be provided with a very specific medical opinion 
as to medical causation. The surmise and supposition of lay 
people relative to this medical issue would, therefore, not be 
necessary. Further, the Commission's own rule requires that in 
these circumstances a referral to a medical panel is the mandated 
course. (Workers' Compensation Rules & Regulations, Rule 1.2.33; 
see Appendix IV). 
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The i... ..jwing 1 nie ol riu t IIUJ i 1 v i • supportive ot ".ubnuttinq 
t h i s issue nedical panel . 
In nampio:,. Home Builders v. I ndus t r i a l Commission of Utah, 
703 P2d 306 0Af (Utah 19Hr)). trie Supreme 
roxe of a medical panel , se t fo r th : 
F i n a l l y , Champion Home Builders argues thai 
t h e A d m i n i s t r a t i v e Law Judge abused h is 
d i s c r e t i o n by not r e f e r r i n g t h i s case to a 
medical panel . Utah Code Ann. 1953, Section 
35-1-77 (Supp. 1983), provides tha t where the 
e m p l o y e r o r i n s u r a n c e c a r r i e r d e n i e s 
l i a b i l i t y , " t h e commission may r e f e r the 
medical aspects of the case to a medical panel 
.' a p p o i n t e d by the Commission.. , ,f (Emphasis 
a d d e d ) . In some c a s e s , such as where the 
e v i d e n c e of c a u s a l connec t ion between the 
work-related event and the injury i s uncer ta in 
or highly technica l* f a i l u r e to refer the case 
t o a m e d i c a l p a n e l may be an abuse of 
d i s c r e t i o n . 
'HMJIIM'I "uttnt " •»; " iviiiih i \\vi Champion Ho me Builders wi th 
approval LS Hone v. J . F . Shea Company. 728 P2d 1 ) 
* • ' Supreme Court s t a t e d : 
Although r e f e r r a l to the medical panel i s not 
requi red by s t a t u t e , we bel ieve in t h i s case 
t h a t the f indings of tha t panel would aid the 
Administrat ive Law Judge. 
/aluated r;n^ ^ the 
request of the Worker- Oompensat; „
 t un.. . h 
various poss ib le causativ*- : ac to r s regarding decedent death, the 
medical aspect:., ni ii - - - a medical panel 
appoin ted by the commission. Because the evidence of casual 
c wpMien i. he w o r k - r e l a t e d a c t i v i t i e s and decedents ' s 
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death is uncertain and highly technical, failure to refer the case 
to a medical panel was an abuse of discretion. 
POINT IV 
THE INDUSTRIAL COMMISSION FAILED IN ITS 
STATUTORY DUTY TO . . . "REVIEW THE ENTIRE 
RECORD . . . n AS IS REQUIRED BY §35-1-82 .54 
(EFFECTIVE THROUGH DECEMBER 3 1 r 1987) . 
§ 3 5 - 1 - 8 2 . 5 4 ( E f f e c t i v e Through December 3 1 , 1987) , r e q u i r e s 
t h e Commission t o r e v i e w t h e e n t i r e r e c o r d when a m a t t e r i s 
submi t t ed t o them p u r s u a n t t o a motion for rev iew. 
The commission/ upon r e f e r r a l of a case t o i t 
by an a d m i n i s t r a t i v e law j u d g e , or upon a 
motion be ing f i l e d wi th i t t o review i t s own 
o r d e r , o r an a d m i n i s t r a t i v e l aw j u d g e ' s 
supplemental order, shall review the entire 
r e c o r d made i n s a i d c a s e , a n d , i n i t s 
d i s c r e t i o n , may ho ld f u r t h e r h e a r i n g s and 
r e c e i v e f u r t h e r e v i d e n c e , and make f i n d i n g s of 
f a c t and e n t e r i t s award t h e r e o n . The award 
of t h e commiss ion s h a l l be f i n a l u n l e s s s e t 
a s i d e by t h e Supreme C o u r t a s h e r e i n a f t e r 
p r o v i d e d . (Emphasis added. ) 
The Commission did not review a t r a n s c r i p t of t h e h e a r i n g as 
i t was not t r a n s c r i b e d u n t i l October 20 , 1987, (R 9 8 ) , n e a r l y a 
m o n t h a f t e r t h e P e t i t i o n f o r W r i t of R e v i e w was f i l e d by 
a p p e l l a n t s . (R 325-328) . L ikewise , t h e r e i s not any i n d i c a t i o n 
i n t h e r eco rd t h a t t he Commission reviewed the e n t i r e r eco rd in 
some o t h e r m a n n e r . A r e v i e w of t h e e n t i r e r e c o r d would have 
r e v e a l e d t h e i d i o p a t h i c n o n i n d u s t r i a l n a t u r e of t h e u n f o r t u n a t e 
dea th of Mr. S teward . 
CONCLUSION 
A p p e l l a n t s seek a r e v e r s a l of t h e I n d u s t r i a l Commission 's 
o p i n i o n i n t h i s c a s e b e c a u s e t h e A l l e n s t a n d a r d s of l e g a l and 
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s p e c i f i c a l nasmuch as 
bv t r e c l a i m a n t h e r e i n . More 
condit - on ^••^pi i 'are* 
re arse :: carrying 
nv t:ie legal caus* 
/ amphetamine intake narcolpesy ^^ 
musual -JL extraordinary exerticr , the 
-asks - - was 
Further, because there was 
i d i c a t i v j * a* the 
s t r e s s u i h-xect I on r equ i i ed by deceden • ]ob was the medi cal 
"I lii'. «lta a f In
 f t'tiir- f i n d i n g of m e d i c a l c a u s a t i o n was 
arbi trary ., u ^ o ^ u u , . , <;> 
Additionall* ommission committer eversible ~^~r in 
Idiiificj -'"!4 v panel foi °' - Latmn and 
also i n : s-1 i - . • • . . - * . ..r- .t . L e recorr1 r i 1 y 
mandated in the administrative appellate process. 
A c c o r d i n g . - uin lie iill^a »t tii'l.ji {r\ r-f leaai and m e d i c a l 
causation were s
 (, the accident i * jompensat... <• . 
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APPENDIX I 
UTAH CODE STATUTES 
35-l-4b.COMPENSATION FOR INDUSTRIAL ACCIDENTS TO BE PAID. 
35-1-77 MEDICAL PANEL-DISCRETIONARY AUTHORITY OF COMMISSION 
TO PEFEP CASE - FINDINGS AND REPORTS - OBJECTIONS TO REPORT 
HEARING EXPENSES. 
35-1-82.54 REVIEW OF CASES AND ORDERS BY COMMISSION-
PROCEDURES - EFFECT OF AWARD 
35-1-8 3 REVIEW BY COURT OF APPEALS 
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compensation for industrial accidents to be paid. 
Every employee mentioned in Section 35-1-43 who is injured, and the da-
pendents of every such employee who is killed, by accident arising out of or in 
the course of his employment, wherever such injury occurred, if the accident 
was not purposely self-inflicted, shall be paid compensation for loss sustained 
on account of the injury or death, and such amount for medical, nurse, and 
hospital services and medicines, and, in case of death, such amount of funeral 
expenses, as provided in this chapter. The responsibility for compensation and 
payment of medical, nursing, and hospital services and medicines, and funeral 
expenses provided under this chapter shall be on the employer and its insur-
ance carrier and not on the employee. 
28 
35-1-77, Medical panel — Discretionary authority of com-
mission to refer case — Findings and reports — 
Objections to report — Hearing — Expenses. 
Upon the filing of a claim for compensation for injury by accident, or for 
death, arising out of or in the course of employment, and where the employer 
or insurance carrier denies liability, the commission may refer the medical 
aspects of the case to a medical panel appointed by the commission and having 
the qualifications generally applicable to the medical panel set forth in sec-
tion 35-2-56. The medical panel shall then make such study, take such X-rays 
and perform such tests, including post-mortem examinations where autho-
rized by the commission, as it may determine and thereafter make a report in 
writing to the commission in a form prescribed by the commission, and also 
make such additional findings as the commission may require. The commis-
sion shall promptly distribute full copies of the report of the panel to the 
applicant, the employer and the insurance carrier by registered mail with 
return receipt requested. Within fifteen days after such report is deposited in 
the United States post office, the applicant, the employer or the insurance 
carrier may file with the commission objections in writing thereto. If no objec-
tions are so filed within such period, the report shall be deemed admitted in 
evidence and the commission may base its finding and decision on the report 
of the panel, but shall not be bound by such report if there is other substantial 
conflicting evidence in the case which supports a contrary finding by the 
commission. If objections to such report are filed the commission may set the 
case for hearing to determine the facts and issues involved, and at such hear-
ing any party so desiring may request the commission to have the chairman of 
the medical panel present at the hearing for examination and cross-examina-
tion. For good cause shown the commission may order other members of the 
panel, with or without the chairman, to be present at the hearing for exami-
nation and cross-examination. Upon such hearing the written report of the 
panel may be received as an exhibit but shall not be considered as evidence in 
the case except as far as it is sustained by the testimony admitted. The ex-
penses of such study and report by the medical panel and of their appearance 
before the commission shall be paid out of the fund provided for by section 
35-1-68. 
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35-1-82.54. Review of cases and orders by commission — 
Procedure — Effect of award [Effective until 
January 1, 1988]. 
The commission, upon referral of a case to it by an administrative law 
judge, or upon a motion being filed with it to review •its own order, or an 
administrative law judge's supplemental order, shall review the entire record 
made in said case, and, in its discretion, may hold further hearings and re-
ceive further evidence, and make findings of fact and enter its award thereon. 
The award of the commission shall be final unless set aside by the Supreme 
Court as hereinafter provided. 
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35-1-83. Review by Court of Appeals [Effective until Janu-
ary 1, 1988]. 
Within 30 days after the commission has given notice of its award, provided 
a motion was previously filed in accordance with this act for review of the 
order or supplemental order upon which the award was based, any affected 
party, including the Division of Finance, may file an action in the Court of 
Appeals for review and determination of the lawfulness of the award. 
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FINDINGS OF FACT 
CONCLUSIONS OF 'LAW 
Is ND • DRDER 
HEARING I 
BUFORE: ' 
APPEARANCES: 
Hearing Room 334, Industrial Commission of Utah, 160 
East 300 South, Salt Lake City, Utah, on November 5, 
1986, at 1:00 o'clock p.m. Said hearing was pursuant 
to Order and Notice of the Commission 
Ricl v J: d G Si ii:ii:t.s::ii on: i, !!l! imi i Listc at :i \ e I ai r 
App 1 i c ant was p res en t and, rep r es ent eu ;») Thoma s R. 
King, Attorney at I aw 
Defendants were represented by Shaui i Howell, Attorney 
at Law 
The sole issue to be resolved by the Industrial Commission in *chis 
case is whether the decedent's death was the result of an injury by accident 
during the course of his employment, or whether his death was the result of .-. 
non-compensable heart attack that occurred as the result :~ * '.jrider lyir \> 
heart conditi on and not because of hi s emp] oyment 
FfMilTNCS OF I'ACTi ' ' * '' ' " 
The decedent* s employer, Lanier • Brugh, is a contract carrier with t"! le 
u. S. rwStal Service for delivery of mail between various locations. The 
decedent's job involved driving a truck'between Salt Lake City and Denver, He 
customarily departed Salt Lake City around 11:00 p.m. and usually arrived in 
r
'" v*--r. Colorado, around 9:00 a.m. the following morning. He would then rest 
, • -parauon for a return trip leaving Denver around 11:00 p.m. and arriving 
hark i:i Ssl* Lak^ C i1 \ f. hv- -.*; - • 
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On the evening of November 10» 1985» the. decedent was notified that 
his truck would be late arriving from Nevada, because of bad weather* He was 
advised to be on standby and to call back periodically, Mrs. Steward 
testified that the anxiety caused by the truck arriving late, combined with 
bad weather, caused the applicant to have a very restless night. Finally, the 
decedent was notified the truck had arrived at 5:00 a.m. and would be ready 
for departure about 5;30 a.m.. 
Upon his arrival in Denver, Mr. Steward called his wife as she had 
requested. This was around 6:20 p.m.. Mrs, Steward testified her husband 
said the roads were bad and he was very tired but was, nevertheless, scheduled 
to make the return trip leaving around 11:00 p.m.. 
Apparently, the decedent started on the return trip to Salt Lake City 
around 11:00 p.m. or shortly thereafter. Enroute on the interstate highway, 
some fifteen to thirty minutes after his departure, the decedent's truck was 
observed moving from the right lane, crossing over two lanes to the left, then 
coming to rest on top of the cement median wall dividing the highway. The 
truck did not overturn and there is no indication that it came to an abrupt 
stop. An eye witness, traveling behind the decedent's truck at the time, 
stopped and tried unsuccessfully to obtain assistance. Finaiiy, another 
motorist arrived. They found Mr. Steward on the passenger side of the cab 
with his arms hanging above his head, making it impossible for them to 
administer CPR. He had no pulse. The Highway Patrol was notified at 11:39 
p.m. and arrived at the scene five minutes later. CPR was administered 
enroute to the hospital. So far as can be determined from the records, there 
was no indication of life, but efforts were made to revive him. 
As stated above, the key issue in this case, like most internal 
failure cases, is whether the injury "arose out of or in the course of 
employment.** Compensability of the applicant's claim depends on evidence 
showing both legal and medical causation. One-half of the test of legal 
causation set down in the recent case of Allen v. Industrial Commission, 46 
Utah Advance Report 3 (1986), is clearly met inasmuch as the decedent's death 
was obviously unexpected. The test is different, however, if there is some 
personal causal contribution in the form of a pre-existing condition. If this 
is the case, the employment contribution must take the form of an exertion or 
stress greater than that of non-employment life. As suggested in the case 
cited in Footnote 8 of the Allen decision: 
"The result would depend on whether there was a personal 
causal element in the form of a previously weakened 
heart. If there was not, compensation would be awarded, 
since the employment contributed something and the 
employee's personal life nothing to the cause of the 
collapse. If there was a previously weakened heart, 
compensation would be denied in spite of the medical 
causal contribution, because legally the personal causal 
contribution was substantial, while the employment added 
nothing to the usual wear and tear of life." « 
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Y|lere m a^ u e s o m e qUestion u.-c -^-t . - - ^. . M ^ ^ 7 a 
"previously weakened heart." In Br Steward*. ^ vhere is no evidence of 
any previously diagnosed heart **ond.t-* c This is true -. ~ many neart attack 
victims. It is arguable, however, that despite the absence of any symptoms or 
diagnosis of a previously weakened heart, the decedent may have had coronary 
artery disease because it is well 1 known that heart attacks almost never occur 
absent an underlying disease. Cardiac arrythmias are sometimes- an exception 
to this genera] rule 
Assuming that legal causation can be established, there is still a 
i leed to prove the decedent's death was medically the result of an exertion or 
stress that occurred as a result of his employment* As noted in the Allen 
case, "the purpose of the medical cause t est is to insure that there is a 
medically demonstrable causal link between the work-related exert ions and the 
unexpected injuries that resulted from those strains". 
The Administrative Law Judge finds the decedent was subjected to the 
^.^owing stress factors; (1) anxiety caused by the late arrival of his truck 
delaying his departure from Salt Lake City, (2) fatigue from having t o drive 
on slippery roads and during a snow storm, both to and from Denver, (3) 
fatigue from inadequate rest prior to his departure from Denver, and (4) t 1 le 
use of amphetamines, probably in greater amounts than usual because of the 
lack of adequate rest. 
The Administrative Law Judge "believes the various possible causative 
factors are succinct 1 y addressed in t he report of Dr, J Joseph Perry, a 
cardiologist, who evaluated the case at the request of the Workers 
Compensation Fund of "Utah, To properly understand this assessment of medical 
causation, the Administrative Law Judge believes it is necessary to quote 
rather extensively from, Dr. Perry's 1 etter of July 29, 1986 He states: 
"It seems clear t hat Mr Steward was not conscious when his 
rig swerved to the left and ran off coming to rest on top 
of t he median wall without apparently overt urning or coming 
to an abrupt stop as it wo il d with a collision. 
Additionally on arrival in the Emergency Department there 
was no gross evidence of physical injury or trauma 
according to the emergency physician. Additionally, the 
photographs sent to me demonstrate very little trauma to 
the rig he was driving. Thus, I think trauma can be 
excluded with a reasonable degree of confidence in this 
case. 
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Complicating the issue is the mention of narcolepsy in the 
medical record. The patient had given a history of sudden 
sleep attacks while driving and had been treated with 
amphetamines by his physician for several years prior to 
his demise. I find no studies in the record to document 
narcolepsy, thus this diagnosis is not secure in this 
individual. 
Of the two scenarios which may have occurred, that is 
falling asleep then suffering a cardiac arrest sometime 
after contacting the median wall, or having the cardiac 
arrest while driving, only the latter seems to have firm 
support. Had he suffered narcolepsy while driving, he 
would have awakened when he left the road (I speak from 
experience) and there seemed to be no event which would 
have been of sufficient severity to cause his death. It is 
remotely possible that the shock and fear of waking up in 
the middle to a serious accident would have been sufficient 
to engender the fatal cardiac arrhythmia, but this does not 
seem very probable. 
In terms of medical probability, it is most likely that he 
experienced a fatal cardiac arrhythmia while driving, lost 
consciousness a few seconds later thus losing control of 
the vehicle and having the accident as reported. It is 
possible that his dextroamphetamine was related to his 
death because it may worsen arrhythmias in susceptible 
individuals. (Emphasis added). 
An autopsy would have been supporting this diagnosis, but 
likely would not have confirmed it with an absolute degree 
of certainty. I suspect it would have shown amphetamine 
present and coronary artery disease present. At this point 
in time exhuming the body would not shed any light on the 
presence of amphetamine. It would, however, document the 
presence or absence of coronary artery disease. In the 
absence of drugs it is extremely unusual for cardiac arrest 
to occur in a person with normal coronary arteries. If the 
absence of coronary artery disease could be documented, 
then the scenario of striking the median wall, waking up 
and then suffering a fatal arrhythmia would become somewhat 
more plausible. Whether or not that has any legal 
significance is of course not within my area of expertise. 
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In summary in terms of reasonable medical probability, the 
patient suffered a fatal arrhythmia while driving and the 
accident was simply the result of his death and subsequent 
loss of control of the vehicle, Ii It ii ] e other possibilities 
exist, they are far less likely I!c> exhume and perform a 
"post-mortem examination of the "body would alter t\ :f;e 
probabilities to an extent , but :i t is highly unlike!, 
would provide definitive answer/* 
For the most part, the Administrative Law Judge adopts the foregoing 
opinions of Dr. Perry as his own Findings of Fact. However, the Administrative 
Law Judge finds that Dr. Perry's opinions do not appear to be based upon all 
of the facts as reflected by the record and for thl s reason the Administ rative 
Law Judge differs from Dr. Perry with respec t. to the ultimate question of 
medical causation. Considering all of the evidence, the Administrative Law 
Judge finds the applicant has met her burden of proof ii i establishing both 
legal and medical causation and that the decedent's death was precipitated by 
the conditions of his employment, 
The possibility exisl : s t hat .despite the absence of any great amount 
of trauma, the decedent may have sustained some significant trauma and it may 
have contributed to his death. It is more probable, however, that he was 
already dead, or at least unconscious, when he struck the median wall because 
all of the attention of the witnesses and the hospi tal staff were focused on 
what appeared to be a heart attack. There was litt le or no attention paid to 
the possiblity of t raumatic injuries resulting from, a collision, 
The Administrative Law Judge has not made any extensive researc h of 
medical literature relative to t he causes of cardiac arrythmias I le has 
reviewed, however, a commentary on cardiac arrythmias which strongly suggests, 
the emotional stress and fatigue under which the decedent was driving may well 
have precipitated, his fatal cardiac arrythmia and the Administrative Law Judge 
so finds. The information relied upon is not quoted herein because it is 
copywrited material. (See Sagall, E. L, and. Reed B C The Heart and t he 
Law, The McMillan Co , I ; a York, 1968, page 536,) 
The decedent1 s average weekly wage at tl le • •.••« o- .- ** is 
alleged to have been $424 .00 per week Tl: ii s qualifies *.he maxi:-iuv. -i^tr: 
ben.ef.it of $2.75 00 per week 
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CONCLUSIONS OF LAW; 
The totality of the evidence showing the decedent's use of 
amphetamines, having a restless night before his departure from Salt Lake City, 
driving in bad weather enroute to Denver, arriving fatigued and apparently 
somewhat distressed over the prospects of having to make the return trip with 
only a few hours rest, and having embarked upon the return trip in a snowstorm, 
demonstrates a body of evidence that preponderates in favor of the applicant 
in showing the precipitating cause of the decedent's fatal cardiac arrythmia 
was due to the conditions of his employment and is therefore compensable under 
the Workers Compensation Act. 
ORDER: 
IT IS THEREFORE ORDERED that the defendants, Lanier-Brugh and/or 
Workers Compensation Fund of Utah, pay applicant compensation at the rate of 
$275.00 per week at intervals of not more than every four weeks for a period 
of 312 weeks for a total of $85,800.00. Accrued amounts, less attorney's fees 
plus interest at the rate of 8% per annum from the date each payment would 
have otherwise been due and payable, shall be paid in a lump sum. 
IT IS FURTHER ORDERED that the defendants, Lanier-Brugh and/or 
Workers Compensation Fund of Utah, pay the medical expenses associated with 
the decedent's hospitalization following his fatal accident, in addition to 
the statutory funeral allowance of $1800.00, plus the additional cost of 
transporting the decedent's body from Colorado to Utah. 
IT IS FURTHER ORDERED that when the above payments end, the 
decedent's widow is to contact the Industrial Commission regarding possible 
additional benefits under Section 35-1-68, Utah Code Annotated. 
IT IS FURTHER ORDERED that immediate notice is to be given by the 
decedent's widow to the Industrial Commission and the insurance carrier in the 
event of her remarriage. 
IT IS FURTHER ORDERED that the defendants, Lanier-Brugh and/or 
Workers Compensation Fund of Utah, pay to Thomas R. King, attorney for the 
applicant, the sum of $10,830.00, for services rendered in this proceeding. 
This fee is in accordance with the Industrial Commission's rule pertaining to 
contingent fees in contested death cases. 
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II IS FURTHER ORDERED that ai 1,3 Mc A :io* 1 for Re* iew of" the for ego ins 
J- ill, be filed in writing within fifteen (15) days of the date hereof 
specifying in detail the particular errors and objections, and, unless so 
filed. thi s Order shaJ 1 be final and not subject ti : • review or appeal. 
Passed by the Industrial Commission 
of Utah, Salt- T.aVp rifv :n ;<• — .3 
ATTEST: 
I 
/ s / Li 1 ida J , S t r a sbur gj 
Linda J. Strasburg 
Commission Secretary 
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I certify that on May 2 ff 1987, a copy of the attached 
Findings of Fact, Conclusions of Law and Order, in the case of Bemice 
Steward, Widow of Dale W. Steward, Deceased, issued May ^tf**" 1987, was 
mailed to the following persons at the following addresses, postage paid: 
Bemice Steward, 1410 West 600 South, SLC, UT 84104 
Thomas R. King, Atty., 2121 South State Street, Suite 205, SLC, 
UT 84115 
Shaun Howell, Atty., Workers Compcmsation Fund of Utah, 560 
South 300 East, SLC, UT 84111 
Lanier-Brugh, Inc., 815 N. W. 11th, Portland, OR 97209 
THE INDUSTRIAL COMMISSION OF UTAH 
By J3/t^~-,^. 
Wilma 
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II- INDUSTRIAL OOHMJS.SIONT 0* iH'fth 
Case No; 86000 1.98 
o 0 °\ 
BEHNICE STEWARD, Widow of 
DALE W. STEWARD, Deceased, 
Applicant, 
vs. 
LANIER-BRUGH and/or 
WORKERS COMPENSATION FI JND OK 
Defendants. 
HTM I, 
ORDER DENYING 
MOTION I? C R REV LEW' 
•* ' -a 
Oi i May 28, 198 7, an Administrative Law Judge of fhe Industrial 
Commission issued Findings of Fact, Conclusions of Law and Order awarding the 
applicant in the above -captioned case dependent death benefits Th-
applicant * s husband died of a "hear t, attack (acute myocardial infarct I en.. 
November 12, 1985 while driving a truck from Denver to Salt Lake City -r, re-
course of his employment wit h the defendant/employer, Lanier-Brugh. 7Y.<-
Administrative Law Judge found the facts supported both a finding : ^-•^•'. 
causation as wel 1 as medical causation, " en vs the Industrial Commit: . -
46 Utah Advanced Reports 3 • (Utah 1986). 
With respect to legal causation, the Administrative Law Judge 
^-^ermined there was no previously diagnosed heart condition and so the 
rtjiuinistrative Law Judge found only normal or usual exertion was required to 
establish legal causation The Administrative Law Judge found that medical 
causation was established because the extra stress the deceased faced during, 
the 24 hours preceding his death most likely led to the arrhythmi a which 
resulted in the myocardial infarction. The Administrative Law Judge relied on 
a medical text discussing the causes of arrhythmia to arrive at this finding. 
Furthermore, the Administrative Law Judge noted that the physician who 
analyzed the possible causes for *~he deceased* s heart attack found that the 
amphetamines the .deceased treatment, :or narcolepsy could have 
contributed to the occurance o: arrhyt/nmia. As both medical and legal 
causation were established, the AummxSirative Law Judge awarded benefits tc 
the widow. 
Oi i JUT le 12 , 19 8 7 , conn s e 1 f o r tl le Wo rker s C omp ens at i on Fund f i led a 
Motion for Review, Counsel for the Workers Compensation Fund contests both 
tl: le finding of lega 1 causation as well as the finding of medical causation. 
W:i th respect to legal causation, counsel for the Workers Compensation Fund 
i lotes the following personal risk factors which counsel finds should have been 
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considered by the Administrative Law Judge in determining whether the higher 
unusual exertion standard applied; obesity, age, moderate to heavy smoking, 
use of amphetamines as treatment for narcolepsy, emphysema and some record of 
possible myocardial related symptoms. In the alternative, if the 
Administrative Law Judge does not find these factors are sufficient to warrant 
application of the higher legal causation standard, counsel for the Workers 
Compensation Fund states the Administrative Law Judge should at least present 
the question of personal risk to a medical panel for its determination. With 
respect to the issue of medical causation, counsel for the Workers 
Compensation Fund finds the list of stress factors existing during the 24 
hours preceding the heart attack cited by the Administrative Law Judge, as 
insufficient for purposes of establishing medical causation. Counsel for the 
Workers Compensation Fund states what medically caused the heart attack needs 
to be determined by a physician and cannot be decided by the Administrative 
Law Judge by way of reference to medical literature. 
The Commission finds the issues to be decided on review are whether 
the Administrative Law Judge's conclusions regarding medical and legal 
causation are supported by the facts in this case. With respect to legal 
causation, the Commission finds that even if the unusual exertion standard is 
applied, the facts relate exertion and/or stress that goes beyond what the 
average person encounters in everyday non-employment life. The Administrative 
Law Judge found the deceased was driving under unusually stressful 
circumstances due to the fact his departure was delayed, he had to drive on 
snow covered roads, he had little or no rest in between the trip to Denver and 
the return trip to Salt Lake City and he was taking amphetamines. This 
combination of stress factors is not encountered by the average person in 
normal non-employment life, and therefore the Commission finds the facts 
support a conclusion of unusual exertion. Consequently, legal causation is 
established and the Administrative Law Judge therefore must be affirmed on 
this issue. 
With respect to medical causation, the Commission also finds the 
Administrative Law Judge should be affirmed. Counsel for the Workers 
Compensation Fund asserts the Administrative Law Judge should have submitted 
the question of medical causation to a physician as the determination of 
medical cause requires medical expertise. The Commission notes however that 
no evidence, medical or otherwise, was submitted by the Workers Compensation 
Fund showing •• av\:dlf f erent cause*: other than stress responsible for the 
arrhythmia which resulted in the heart attack. The only medical opinion 
submitted verifies that the amphetamines could have been a contributing cause 
to the arrhythmia and the Administrative Law Judge relied on consensus medical 
opinion that stress, fatigue and stimulants are all common precipitating 
causes of cardiac arrhythmias. The chart relied on by the Administrative Law 
Judge is reproduced below: 
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A 
tJ$?fc °! 
:'*** ,-r. a, screws, particularly acu' e 
Exertion, particularly under unusual conditions (e g , 
cold, alcohol, fatigue, excitement., etc, ,) 
Infectioi i, thy i: otoxicosis, and other nonca- J: -.: . ' -^ ss 
Medication, especial ly digitalis over dosage, 
Stimulants such as tobacco, coffee, tea, „~ alcohol in 
sensitive subjects 
Hcute hypoglycemia (low blood sugar) 
Therapeutic procedures such as surgery, anesthesia, and 
nerve block. Q
 Trauma, particularly to the heart 
Electric current as with accidental electric shock or 
e1ectrotherapeu11c procedures 
10*" ' Reflex vagal stimulation (e.g., acute gastritis, biliary 
colic, and other gastrointestinal disorders) 
11
 # Acute cardiac disease (e.g,, acute myocardial Infraction, 
acute myocardial ischemia, cardiac contusion, congestive 
h e a r t f a i 1 u r e, e t: c ) 
* adapted front Risemai :i, • 3 E I? , a i i i Sagal 1, E.L i Cardiac 
Arrhythmias; Electrocardiography, Diagnosis, Treatment The 
Macmillian Co , New York, 1963, 
The Commission finds that In absence of evidence showing another cause, the 
Administrative Law Judge acted within his discretion in relying on a 
combination of medical evidence from, the one, medical opinion submitted and the 
consensus medical opinion as related i n the medical text referred to by the 
Administrative Law Judge As there is sufficient evidence to support the 
Administrative Law Judge*s findings regarding both legal and medical 
causation,, the Commission must deny the Workers Compensation Fund's Motion for 
Review and affirm the Pi dminlstrative Law Judge, 
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ORDER: 
IT IS THEREFORE ORDERED that the Workers Compensation Fund's June 12, 
1987 Motion for Review is denied and the Administrative Law Judge's May 28, 
1987 Order is hereby affirmed and final with further appeal to the Court of 
Appeals only per U.C.A. 35-1-83. 
John Florez J c^^^ 
Commissioner 
Passed by the Industrial Commission 
of Utgh, Salt Lake City, Utah, this 
45 2^3 
CERTIFICATE OF MAILING 0<f] 
I certify that on August ^3J[_% 1987, a copy of the attached 
ORDER DENYING MOTION FOR REVIEW in the case of BERNICE STEWARD, Widow of DALE 
W. STEWARD, Deceased was mailed to the following persons at the following 
addresses, postage paid; 
Bernice Steward 
1410 West 600 South 
Salt Lake City, UT 84104 
Thomas R. King 
Attorney at Law 
2121 South State, Suite 205 
Salt Lake City, UT 84115 
Shaun Howell 
Attorney at Law 
Workers Compensation Fund of Utah 
P.O. Box 45420 
SLC, UT 84145-0420 
Lanier-Brugh, Inc. 
815 N. W. 11th 
Portland, OR 97209 
Richard G. Sumsion, Administrative Law Judge 
Janet L. Moffitt, Administrative Law Judge 
INDUSTRIAL COMMISSION OF UTAH 
Pamela Hayes 
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WORKERS' COMPENSATION RULES AND REGULATIONS 
GUIDELINES FOR UTILIZATION OF MEDICAL PANEL 
Workers' Compensation Rules & Regulations 
1.2- 33. GUIDELINES FOR UTILIZATION OF MEDICAL PANEL 
- Pursuant to Section 35-1-77, U.C.A. the 
Commission adopts the following guidelines 
in determining the necessity of submitting 
a case to a medical panel: 
(a) A panel will be utilized where: 
1. One or more significant medical 
issues are involved. 
Generally a significant medical 
issue must be shown by conflict-
ing medical reports. The issues 
of permanent partial impairment 
will be considered significant if 
conflicting medical reports vary 
with a rating more than 5% of the 
whole person; or if the temporary 
total cut off date varies more 
than 90 days; or if the amount of 
medical expense in controversy is 
more than $2,000. 
2. In the opinion of the Commision 
the medical issues are so inter-
twined with the events that a 
determination of whether an acci-
dent has occurred cannot be made 
without first resolving medical 
consideration. 
(b) Where in the opinion of the Commis-
sion, the evidence is insufficient for 
the Commission to make a final deter-
mination, the Commission may require an 
independent medical evaluation. Costs 
to be assessed against the employer 
and/or Second Injury Fund. 
23 
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Workers' Compensation Rules & Regulations 
(c) A hearing on objections to the panel 
report may be scheduled if there is a 
proffer of conflicting medical testi-
mony or an indication that all relevant 
medical evidence was not considered by 
the panel. 
(d) The Commission may authorize an injured 
worker to be examined by another physi-
cian for the purpose of obtaining a 
further medical examination or evalua-
tion pertaining to the medical issues 
involved, and to obtain a report 
addressing these medical issues in all 
cases where: 
1. The treating physician has failed 
or refused to give an impairment 
rating. 
2. The employer or doctor 
considers the claim to be 
non-industrial. 
3. A substantial injustice may 
occur without such further 
evaluation. 
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a normal" TSH during those two to eight 
ms: ..Adverse reactions, other than those 
srthyroidism because of therapeutic over-
ially or during the maintenance period are 
)OSAGE). * 
allergic skin reactions have been reported 
thyronine sodium, SK&F) Tablets. 
oms—Headache, irritability, nervousness, 
irdia, increased bowel motility and men-
jes. Angina pectoris or congestive.heart 
lduced or aggravated. Shock may also de-
rerdosage may result in symptoms resem-
rm. Chronic excessive dosage will produce 
nptoms of hyperthyroidism. , 
rerdossge—Dosage should be reduced or 
rily discontinued if signs and symptoms of 
ar. Treatment may be reinstituted at a 
normal individuals, normal hypothalamic-
axis function is restored in six to eight 
aid suppression. «• * • 
ite massive thyroid hormone overdosage is 
tg gastrointestinal absorption of the drugs 
ig central and peripheral effects, mainly 
d sympathetic activity. Vomiting may be 
if further gastrointestinal absorption can 
jvented and barring contraindications such 
ons, or loss of the gagging reflex. Treatment 
ad supportive. Oxygen may be administered 
maintained. Cardiac glycosides may be indi-
re heart failure develops. Measures to con-
lycemia, or fluid loss should be instituted if 
energic agents, particularly propranolol, 
advantageously in the treatment of in-
etic activity. Propranolol may be adminis-
sly at a dosage of 1 to 3 mg. over a 10-minute 
80 to 160 mg./day, especially when no con-
sist for its use. 
ministration: The dosage of thyroid hor-
ined by the indication and must in every 
lalized according to patient response and 
igs. 
es are given orally. In acute, emergency 
table lev< thyroxine sodium may be given 
hen oral tt ministration is not feasible or 
ho treatment of myxedema com: «u luring 
nutrition. Injectable liothyronine sodium is 
>m Smith Kline &French Laboratories upon 
nvestigational status, for the treatment of 
. Intramuscular administration of these two 
not advisable because of reported poor ab-
liothyronine sodium, SK&F) Tablets once-
ecommended; although liothyronine sodium 
tf, its metabolic effects persist for a few days 
tinuance. 
roidism: Recommended starting dosage is 
Daily dosage then may be increased by 12.5 
ery one or two weeks. Usual maintenance 
ncg. daily. Smaller doses may be fully effec-
atients, while dosage of 100 meg. daily may 
i others. 
,et and dissipation of action of liothyronine 
s compared with levothyroxine sodium (T4\ 
clinicians to prefer its use in patients who 
e susceptible to the untoward effects of thy-
on. However, the wide swings in serum T3 
low its administration and the possibility of 
iced cardiovascular side effects tend to coun-
e stated advantages. 
tyronine sodium, SK&F) Tablets may be used 
' to levothyroxine (T4) during radioisotope 
•edures, since induction of hypothyroidism in 
more abru ^  and can be of shorter duration, 
e preferred when impairment of peripheral 
T4 and T3 is suspected. 
Recommended starting dosage is 5 meg. 
ay be increased by 5 to 10 meg. daily every 
*eks. When 25 meg. daily is reached, dosage 
increased by 12.5 or 25 meg. every one or two 
maintenance dose is 50 to 100 meg. daily. 
loma: Myxedema coma is usually precipi-
ypothyroid patient of long standing by inter-
is or drugs such as sedatives and anesthetics 
e considered a medical emergency. A 'Cyto-
n Kit for the emergency treatment of myx-
\s available fTom Smith Kline &French Labo-
I request, under investigational status. In-
lich accompany this kit provide information 
ation. 
Hypothyroidism: Recommended starting 
eg. daily, with a 5 meg. increment every three 
intil the desired response is achieved. Infants 
i old may require only 20 meg. daily for main-
one year, 50 meg. daily may be required. 
Above three years, full adult dosage may be necessary (See 
PRECAUTIONS;-Pediatric Use), w «:m#sd v r ^ s ^ ^ 1? 
Simple (non-toxic) Goiter. -Recommended starting dosage 
is 5 meg/daily. This dosage may be increased by '5 -to -10 
meg. daily'every oneor two weeks. 'When* 25 "meg. daily is 
reached, dosage may be increaseil every week or "two by 
12.5 or 251mcg. Usual maintenance dosage is 75 meg. daily. 
In the elderly or in children, therapy should be started with 5 
meg. daily and increased only by 5 meg. increments at the 
recommended intervals. ' ' * ^ 
When switching a patient to Cytomel (liothyronine sodium, 
SK&F) Tablets from thyroid, L-thyroxine or thyroglobulin, 
discontinue the other medication, initiate 'Cytomel' at a low 
dosage, and increase gradually according to the patient's 
response. When selecting a starting dosage; bear in mind 
that this drug has a rapid onset of action, and that residual 
effects of the.other thyroid preparation may persist for the 
first several weeks of therapy. 
Thyroid Suppression Therapy: Administration of thyroid 
hormone in doses higher than those produced physiologi-
cally by the gland results in suppression of the production of 
endogenous hormone. This is the basis for the thyroid sup-
pression test and is used as an aid in the diagnosis of patients 
with signs of mild hyperthyroidism in whom baseline labora-
tory tests appear normal or to demonstrate thyroid gland 
autonomy in patients with Graves' ophthalmopathy. l31I 
uptake is determined before and after the administration of 
the exogenous hormone. A 50 percent or greater suppression 
of, uptake indicates a normal thyroid-pituitary axis and thus 
rules but thyroid gland autonomy. 
Cytomel (liothyronine sodium, SK&F) Tablets are given in 
doses of 75-100 meg./day for seven days, and radioactive io-
dine uptake is determined before and after administration of 
the hormone. If thyroid function is under normal control, the 
radioiodine uptake will drop significantly after treatment. 
Cytomel (liothyronine sodium, SK&F) Tablets should be ad-
ministered cautiously to patients in whom there is a strong 
suspicion of thyroid gland autonomy, in view of the fact that 
the exogenous hormone effects will be additive to the endoge-
nous source. \ 
How Supplied: Cytomel Giothyronine sodium, SK&F) 
tablets: 5 meg. in bottles of 100; 25 meg. in bottles of 100 and 
1000; and 50 meg. in bottles of 100. 
CY-.L30 
Shown in Product Identification Section, page 429 
DARBID® TABLETS. 5 mg. $ 
[dahr'bid] 
(brand of isopropamide iodide) 
Description: Darbid (brand of isopropamide iodide) is avail-
able as a tablet for oral administration. Each round, pink, 
coated tablet is imprinted SKF and D62 and contains isopro-
pamide iodide equivalent to 5 mg of isopropamide. Inactive 
ingredients consist of acacia, calcium sulfate, FD&C Red No. 
3, FD&C Yellow No. 6, gelatin, iron oxide, mineral oil, starch, 
stearic acid, sucrose, talc, titanium dioxide and trace 
amounts of other inactive ingredients. 
Chemically, Darbid (isopropamide iodide, SK&F) is (3-carbam-
oyl-3, 3-diphenylpropyl) diisopropylmethyl ammonium io-
dide. 
Actions: Isopropamide iodide is a synthetic anticholinergic 
that produces 10- to 12-hour gastric acid antisecretory effect 
and gastrointestinal antispasmodic response in man. 
Indications: 'Darbid* is effective as adjunctive therapy in 
the treatment of peptic ulcer. 
'DARBID' HAS NOT BEEN SHOWN TO BE EFFECTIVE 
AS SOLE THERAPY IN CONTRIBUTING TO THE HEAL-
ING OF PEPTIC ULCER, DECREASING THE RATE OF 
RECURRENCE OR PREVENTING COMPLICATIONS. 
To be effective, dosage must be titrated to the individual pa-
tient's needs. 
Contraindications: Glaucoma; obstructive uropathy (e.g., 
bladder neck obstruction due to prostatic hypertrophy); ob-
structive disease of the gastrointestinal tract (as in achala-
sia, pyloroduodenal stenosis, etc.); obstructive or paralytic 
ileus, intestinal atony of the elderly or debilitated patient; 
unstable cardiovascular status in acute hemorrhage; severe 
ulcerative colitis; toxic megacolon complicating ulcerative 
colitis; myasthenia gravis. 
Warnings: In the presence of a high environmental temper-
ature, heat prostration (fever and heat stroke due to de-
creased sweating) can occur. 
In patients with diarrhea due to incomplete intestinal ob-
struction (especially those with ileostomy or colostomy), 
treatment with Darbid (isopropamide iodide, SK&F) would be 
inappropriate and possibly harmful. 
'Darbid' may produce drowsiness or blurred vision. In this 
event, the patient should be warned not to engage in activi-
ties requiring mental alertness such as operating a motor 
vehicle or other machinery or perform hazardous work while 
taking this drug. 
Usage in Pregnancy: In pregnancy, lactation, and in women 
who may bear children, the potential benefits of the drug 
must be weighed against possible hazards. _ 
52 
Precautions: Use cautiously in elderly patients: 
Since the iodine' in isopropamide iodide may alter PBI test 
results and will suppress I131 uptake, it is suggested that 
therapy be discontinued one week prior to these.tests; Also, 
iodine skin rash niay.occur rarely. 
Use with caution inpatients with: 
Autonomic neuropathy. 
Hepatic or renal disease 
Ulcerative colitis (large doses may suppress intestinal motil-
ity to the point of producing paralytic ileus, and the use of 
this drug may precipitate or aggravate the seriouscomplica-
tion of toxic megacolon). 
Hyperthyroidism, coronary heart disease, congestive heart 
failure, cardiac arrhythmia, hypertension and nonobstruct-
ing prostatic hypertrophy. 
Hiatal hernia associated with reflux esophagitis (anticholin-
ergic drugs may aggravate this condition). 
It should be noted that the use of anticholinergic drugs in the 
treatment of gastric ulcer may produce a delay in gastric 
emptying time (antral stasis) and, thus, complicate therapy. 
Do not rely on the use of the drug in the nresence of complica-
tion of biliary tract disease. 
Investigate any tachycardia before giving anticholinergic 
(atropine-like) drugs, since they may increase the heart rate. 
With overdosage, a curare-like action may occur. 
Adveree Reactions: Anticholinergics produce certain phar-
macological effects which may be desirable or undesirable, 
depending upon the individual patient's response. The physi-
cian must delineate these. 
Adverse reactions which have occurred with Darbid (isopro-
pamide iodide, SK&F) include: xerostomia (dry mouth); uri-
nary hesitancy and retention; blurred vision; tachycardia; 
palpitations; mydriasis (dilatation of the pupils); cycloplegia; 
constipation; bloated feeling; nausea; dysphagia,- fever; and 
nasal congestion. 
Other adverse reactions possible with anticholinergics in-
clude: increased ocular tension; loss of taste; headaches; ner-
vousness; drowsiness; weakness; dizziness; insomnia; vomit-
ing; impotence; suppression of lactation; severe allergic reac-
tion or drug idiosyncrasies including anaphylaxis; urticaria 
and other dermal manifestations; some degree of mental 
confusion and/or excitement, especially in elderly persons. 
Decreased sweating may occur. It should be noted that ad-
renergic innervation of the eccrine sweat glands on the 
palms and soles *rakes complete control of sweating impossi-
ble. An end pOi.*:: of complete anhidrosis cannot occur be-
cause lf-ge doses of drug would be rec ' -<>d, and this would 
produce severe side effects from parasympathetic paralysis. 
Dosage and Administration: Not for use in children un-
der 12. Adults and children over 12—Usual starting dose is 
one 5 mg. tablet b.i.d. (every 12 hours). Patients with severe 
symptoms may require two 5 mg. tablets b.i.d., or more. Dos-
age should be individualized and titrated to the patient's 
need for greatest therapeutic effect. 
Overdosage: Involves the cardiovascular, respiratory, gas-
trointestinal, central and peripheral nervous systems. 
SYMPTOMS—May include dryness of mouth, dysphagia, 
thirst, blurred vision, dilated pupils, photophobia, fever, 
rapid pulse and respiration, disorientation. Depression and 
circulatory collapse may result from severe overdosage. 
TREATMENT—Gastric lavage, repeated several times. 
Respiratory depression should be promptly treated by the 
use of oxygen and stimulants. If marked excitement is pres-
ent, one of the short-acting barbiturates, chloral hydrate, or 
gas anesthesia may be used. Otherwise do not administer 
sedation. Hyperpyrexia may be treated with physical cooling 
measures. Force fluids by mouth or, if necessary, by intrave-
nous administration. 
While pilocarpine or similar drugs are ^  sometimes recom-
mended for the relief of dry mouth, many authorities feel 
that these drugs are not indicated, since they relieve the 
minor peripheral effect but do not influence the more serious 
central effects and, thus, may merely mask signs of drug 
activity. If photophobia occurs, the patient should be kept in 
a darkened roo~ 
How Suppliea. Tablets, 5 mg., in bottles of 50. 
Shown in Product Identification Section, page 429 
DB-L16 
DEXEDR1NE® 
[dex 'eh-dreen ] 
(brand of dextroamphetamine sulfate) 
SPANSULE® CAPSULES, 
TABLETS and ELIXIR 
Warning: 
AMPHETAMINES HAVE A HIGH POTENTIAL FOR 
ABUSE. THEY SHOULD THUS BE TRIED ONLY IN 
WEIGHT REDUCTION PROGRAMS FOR PATIENTS 
IN WHOM ALTERNATIVE THERAPY HAS BEEN 
INEFFECTIVE. ADMINISTRATION OF AMPHETA-
MINES FOR PROLONGED PERIODS OF TIME IN 
Continued on next page 
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Smith Kline & French—Cont. 
OBESITY MAY LEAD TO DRUG DEPENDENCE AND 
MUST BE AVOIDED. PARTICULAR ATTENTION 
SHOULD BE PAID. TO THE POSSIBILITY OF SUB-
JECTS OBTAINING AMPHETAMINES FOR NON-
THERAPEUTIC USE OR DISTRIBUTION TO OTH-
ERS, AND THE DRUGS SHOULD BE PRESCRIBED 
OR DISPENSED SPARINGLY. 
Description: Dexedrine (dextroamphetamine sulfate, 
SK&F) is the dextro isomer of the compound a\l -amphetr 
amine sulfate, a sympathomimetic amine of the amphet-
amine group. Chemically, dextroamphetamine is d-alpha-
methylphenethylamine, and is present in all forms of'Dexe-
drine' as the neutral sulfate. 
Spansule® capsules 
Each ;Spansule' sustained release capsule is so prepared that 
an initial dose is released promptly and the remaining medi-
cation is released gradually over a prolonged period: 
Each capsule, with brown cap and natural body, contains 
dextroamphetamine sulfate as follows: 5 mg. imprinted SKF 
and E12, 10 mg. imprinted SKF and E13, 15 mg. imprinted 
SKF and E14. Inactive ingredients consist of acacia, benzyl 
alcohol, calcium sulfate, cetylpyridinium chloride, FD&C 
Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 5 (tartra-
zine), FD&C Yellow No. 6, gelatin, glyceryl distearate, glyc-
eryl monostearate, sodium lauryl sulfate, starch, sucrose, 
wax and trace amounts of other inactive ingredients. 
Tablets 
Each triangular, orange, scored tablet is debossed SKF and 
E19 and contains dextroamphetamine sulfate, 5 mg. Inactive 
ingredients consist of calcium sulfate, FD&C Yellow No. 5 
(tartrazine), FD&C Yellow No. 6, gelatin, lactose, mineral oil, 
starch, stearic acid, sucrose, talc and trace amounts of other 
inactive ingredients. 
Elixir 
Each 5 ml. (one teaspoonful) of clear, orange-colored, orange-
flavored liquid contains dextroamphetamine sulfate, 5 mg., 
and alcohol, 10%. Inactive ingredients consist of benzoic 
acid, citric acid, FD&C Yellow No. 5 (tartrazine), FD&C Yel-
low No. 6, flavor, sucrose, water and wine. 
Clinical Pharmacology: Amphetamines are non-cate-
cholamine, sympathomimetic amines with CNS stimulant 
activity. Peripheral actions include elevations of systolic a/iJ 
diastolic blood pressures and weak bronchodilator and respi-
ratory stimulant action. 
There is neither specific evidence which clearly establishes 
the mechanism whereby amphetamines produce mental and 
behavioral effects in children, nor conclusive evidence re-
garding how these effects relate to the condition of the cen-
tral nervous system. 
Drugs of this class used in obesity are commonly known as 
"anorectics" or "anorexigenics." It has not been established, 
however, that the action of such drugs in treating obesity is 
primarily one of appetite suppression. Other central nervous 
system actions, or metabolic effects, may be involved, for 
example.--
Adult obese subjects instructed in dietary management and 
treated with "anorectic" drugs lose more weight on the aver-
age than those treated with placebo and diet, as determined 
in relatively short-term clinical trials. 
The magnitude of increased weight loss of drug-treated pa-
tients over placebo-treated patients is only a fraction of a 
pound a week. The rate of weight loss is greatest in the first 
weeks of therapy for both drug and placebo subjects and 
tends to decrease in succeeding weeks. The origins of the 
increased weight loss due to the various possible drug effects 
are not established. The amount of weight loss associated 
with the use of an "anorectic" drug varies from trial to trial, 
and the increased weight loss appears to be related in part to 
variables other than the drug prescribed, such as the physi-
cian-investigator, the population treated, and the diet pre-
scribed. Studies do not permit conclusions as to the relative 
importance of the drug and nondrug factors on weight loss. 
The natural history of obesity is measured in years, whereas 
the studies cited are restricted to a few weeks' duration; thus, 
the total impact of drug-induced weight loss over that of diet 
alone must be considered clinically limited. 
Dexedrine (dextroamphetamine sulfate, SK&F) Spansule 
capsules are formulated to release the active drug substance 
in vivo in a more gradual fashion than the standard formula-
tion, as demonstrated by blood levels. The formulation has 
not been shown superior in effectiveness over the same dos-
age of the standard, noncontrolled-release formulations 
given in divided doses. 
Pharmacokinetics 
Elixir—Ingestion of 10 mg. of dextroamphetamine sulfate in 
elixir form by healthy volunteers produced an average peak 
dextroamphetamine blood level of 33.2 ng./ml. The half-life 
was 11.75 hours. The average urinary recovery was 38% in 
48 hours. 
Tablet—The single ingestion of two 5 mg. tablets by healthy 
volunteers produced an average peak dextroamphetamine 
blood level of 29.2 ng./ml. at .2 hours post-administration. 
The average half-life was 10.25 hours. The average, urinary 
recovery was 45% in 48 hours. 
'Spansule' capsule—Ingestion of a 'Spansule' capsule con-
taining 15 mg. radiolabeled dextroamphetamine sulfate-by 
healthy volunteers produced a peak blood level of radioactiv-
ity, on the average, at 8-10 hours postradministration with 
peak urinary recovery seen at 12-24 hours. 
Indications and Usage: Dexedrine (dextroamphetamine 
*#«lfat* SK&F) Vindicated: 
2. In Attention "Deficit Disorder with Hyperactivity, as an 
integral part of a total treatment program which typically 
includes other remedial measures (psychological, educa-
tional, social) for a stabilizing effect in children with a 
behavioral syndrome characterized by the following group 
of developmentally inappropriate symptoms: moderate to 
severe distractibility, short attention span, hyperactivity, 
emotional lability, and impulsivity. The diagnosis of this 
syndrome should not be made with finality when these 
symptoms are only of comparatively recent origin. Nonlo-
calizing (soft) neurological signs, learning disability, and 
abnormal EEG may or may not be present, and a diagnosis 
of central nervous system dysfunction may or may not be 
warranted. 
3. In Exogenous Obesity, as a short-term (a few weeks) ad-
junct in a regimen of weight reduction based on caloric 
restriction, for patients refractory to alternative therapy, 
e.g., repeated diets, group programs, and other drugs. The 
limited usefulness of amphetamines (see CLINICAL 
PHARMACOLOGY) should be weighed against possible 
risks inherent in use of the drug, such as those described 
below. 
lilt Wllllft<WJmillW"iiMasi, moderate to severe hyperten-
sion, hyperthyroidism, known hypersensitivity or idiosyn-
crasy to the sympathomimetic amines, glaucoma. 
Agitated states. 
Patients with*a history of drug abuse. 
During or within 14 days following the administration of 
monoamine oxidase inhibitors (hypertensive crises may re-
sult). 
Warning: When tolerance to the "anorectic" effect devel-
ops, the recommended dose should not be exceeded in an 
a xempt to increase the effect; rather, the drug should be 
discontinued. 
Precautions: 
LtOtrnmr Caption Ja to be ex*rri*ri in j n * » a ^ 
The least amount feasible should be prescribed or dispensed 
at one time in order to minimize the possibility of overdos-
age. 
These products contain FD&C Yellow # 5 (tartrazine), which 
may cause allergic-type reactions (including bronchial 
asthma) in certain susceptible individuals. Although the 
overall incidence of FD&C Yellow # 5 (tartrazine) sensitivity 
in the general population is low, it is frequently seen in pa-
tients who also have aspirin hypersensitivity. 
Information for Patients: Amphetamines may impair the 
ability of the patient to engage in potentially hazardous ac-
tivities such as operating machinery or vehicles; the patient 
should therefore be cautioned accordingly. 
Drug Interactions 
Acidifying agents—Gastrointestinal acidifying agents (gua-
nethidine, reserpine, glutamic acid HC1, ascorbic acid, fruit 
juices, etc.) lower absorption of amphetamines. Urinary 
acidifying agents (ammonium chloride, sodium acid 
phosphate, etc.) increase the concentration of the ionized 
species of the amphetamine molecule, thereby increasing 
urinary excretion. Both groups of agents lower blood levels 
and efficacy of amphetamines. 
Adrenergic blockers—Adrenergic blockers are inhibited by 
amphetamines. 
Alkalinizing agents—Gastrointestinal alkalinizing agents 
(sor"'*:! bicarbonate, etc.) increase absorption of ampheta-
mines. Urinary alkalinizing agents (acetazolamide, some 
thiazides) increase the concentration of the non-ionized spe-
cies of the amphetamine molecule, thereby decreasing uri-
nary excretion. Both groups of agents increase blood levels 
and therefore potentiate the actions of amphetamines. 
Antidepressants, tricyclic—Amphetamines may enhance 
the activity of tricyclic or sympathomimetic agents; d-
amphetamine with desipramine or protriptyline and possi-
bly other tricyclics cause striking and sustained increases in 
the concentration of d-amphetamine in the brain; cardiovas-
cular effects can be potentiated. 
MAO inhibitors—MAOI antidepressants, as well as a metab-
olite of furazolidone, slow amphetamine metabolism. This 
slowing potentiates amphetamines, increasing their effect 
on the release of norepinephrine and other monoamines 
from adrenergic nerve endings; this can cause headaches 
and other signs of hypertensive crisis. A variety of neurologi-
cal toxic effects and malignant hyperpyrexia can occur, 
sometimes with fatal results. 
Antihistamines—Amphetamines may counteract the seda-
tive effect of antihistamines. 
Antihypertensives—Amphetamines may i 
hypotensive effects of antihypertensives. 
Chlorpromazine—Chlorpromazine • .blocks 
norepinephrine reuptake, thus inhibiting th< 
lant effects of amphetamines, and can be ui 
phetamine poisoning. 
Ethosuximide—Amphetamines may delay in 
tion of ethosuximide. 
Haloperidol—Haloperidol blocks dopamine a 
rine reuptake, thus inhibiting the central st 
of amphetamines. 
Lithium carbonate—The antiobesity and stir. 
of amphetamines may be inhibited by lithii 
Meperidine—Amphetamines potentiate the 
of meperidine. 
Methenamine therapy—Urinary excretior 
mines is increased, and efficacy is reduced 
agents used in methenamine therapy. 
Norepinephrine—Amphetamines enhance 
effect of norepinephrine. 
Phenobarbital—Amphetamines may delay 
sorption of phenobarbital; co-administration 
tal may produce a synergistic anticonvulsarj 
Phenytoin—Amphetamines may delay intest 
of phenytoin; co-administration of phenytoin 
synergistic anticonvulsant action. 
Propoxyphene—In cases of propoxyphene o 
phetamine CNS stimulation is potentiated ai 
sions can occur. 
Veratrum alkaloids—Amphetamines inhibi 
sive effect of veratrum alkaloids. 
Drug/Laboratory Test Interactions 
• Amphetamines can cause a significant 
plasma corticosteroid levels. This increaa 
the evening. 
• Amphetamines may interfere with urinar 
minations. 
Carcinogenesis/Mutagenesis: Mutagenicity 
long-term studies in animals to determine tr 
potential of Dexedrine (dextroamphetamine 
have not been performed. 
Pregnancy—Teratogenic Effects: Pregnane 
'Dexedrine' has been shown to have embryotc 
genie effects when administered to A/Jax m 
mice in doses approximately 41 times the ma 
dose. Embryotoxic effects were not seen in 
white rabbits given the drug in doses 7 times t 
nor in rats given 12.5 times the maximum 
There are no adequate and well-controlled 8 
nant women. 'Dexedrine' should be used dur 
only if the potential benefit justifies the poter 
fetus. 
Nonteratogenic Effects: Infants born to mot! 
on amphetamines have an increased risk of pr 
ery and low birth weight. Also, these infants n 
symptoms of withdrawal as demonstrated by 
eluding agitation, and significant lassitude. 
Nursing Mothers: It is not known whether t 
creted in breast milk; efforts to measure am 
breast milk have been unsuccessful. Because n 
excreted in human milk, caution should be e 
'Dexedrine' is administered to a nursing wor 
Pediatric Use: Long-term effects of ampheta 
dren have not been well established. 
Amphetamines are not recommended for us 
agents in children under 12 years of age, or in c 
3 years of age with Attention Deficit Disorder 
tivity described under INDICATIONS AND 1 
Clinical experience suggests that in psychoti* 
ministration of amphetamines may exacerbat 
behavior disturbance and thought disorder. 
Amphetamines have been reported to exacerb 
phonic tics and Tourette's syndrome. Ther 
evaluation for tics and Tourette's ryndrome ii 
their families should precede use of stimulant 
Data are inadequate to determine whether chi 
tration of amphetamines may be associated 
inhibition; therefore, growth should be mon 
treatment. 
Drug treatment is not indicated in all cases of
 t 
icit Disorder with Hyperactivity and should 
only in light of the complete history and eva 
child. The decision to prescribe amphetamin 
pend on the physician's assessment of the c 
severity of the child's symptoms and their ap 
for his/her age. Prescription should not depenc 
presence of one or more of the behavioral chj 
When these symptoms are associated with acu 
tions, treatment with amphetamines is usui 
cated. 
^ d y e ^ s ^ e a ^ i o n s ^ 
Nervous System: Psychotic episodi 
mended doses (rare), overstimulation, restlessn 
insomnia, euphoria, dyskinesia, dysphoria, t 
jible revisions 
erbation of motor and phonic tics"and Tourette's 
jstmai: uryness ot tne mouth, unpleasant taste, 
constipation, other gastrointestinal disturbances. 
and weight loss may occur as undesirable effects 
ihetamines are used for other than the anorectic 
Urticaria. 
Impotence, ^ cnanges m noioo. 
me and Dependence: ^Dextroamphetamine sul-
thedultll controlled substance, 
lines have been extensively abused. Tolerance, 
jychological dependence, and severe social disabil-
ccurred. There are reports of patients who have 
the dosage to many times that recommended, 
jsation following prolonged high dosage adminis-
sults in extreme fatigue and mental depression; 
•e also noted on the sleep EEG. 
ions of chronic intoxication with amphetamines 
vere dermatoses, marked insomnia, irritability, 
ity, and personality changes. The most severe 
ion of chronic intoxication is psychosis, often d i -
stinguishable from schizophrenia. This is rare 
imphetamines. ». • * 
ge: Individual patient response to ampheta-
es widely. While toxic symptoms occasionally oc-
liosyncrasy at doses as low as 2 mg., they are rare 
of less than 15 mg.; 30 mg. can produce severe 
/et doses of 400 to 500 mg. are not necessarily fa-
i oral LDso of dextroamphetamine sulfate is 96.8 
Manifestations of acute overdosage with am-
s include restlessness, tremor, hyperreflexia, 
ration, confusion, assaultiveness, hallucinations, 
ddtprtwion usually follow the centrafitimuW-
ttl«regftct»incbidftajThythnii^hypeTtga^^ 
n and circulatory QQlkpsey Gastrointestinal 
include nausea, vomiting, diarrhea, and abdomi-
.. Fatal poisoning is usually preceded by convul-
INT—Management of acute amphetamine intoxi-
irge\y symptomatic and includes gastric lavage 
n with a barbiturate. Experience with hemodialy-
jneal dialysis is inadequate to permit recommen-
his regard. Acidification of the urine increases 
me excretion. If acute, severe hypertension com-
iphetamine overdosage, administration of intra-
entolamine (Regitine®, CIBA) has been sug-
vever, a gradual drop in blood pressure will usu-
when sufficient sedation has been achieved, 
azine antagonizes the central stimulant effects of 
nes and can be used to treat amphetamine intoxi-
of the 'Spansule' capsule medication is coated for 
ease, therapy directed at reversing the effects of 
d drug and at supporting the patient should be 
or as long as overdosage symptoms remain. Sa-
tics are useful for hastening the evacuation of 
. have not already released medication. 
id Administration: Regardless of indication, 
nes should be administered at the lowest effec-
and dosage should be individually adjusted. Late 
ses—particularly with the 'Spansule* capsule 
Id be avoided because of the resulting insomnia. 
: Usual dose 5 to 60 milligrams per day in di-
, depending on the individual patient response, 
seldom occurs in children under 12 years of age: 
hen it does, Dexedrine (dextroamphetamine su. 
) may be used. The suggested initial dose for pa-
6-12 is 5 mg. daily; daily dose may be raised in 
of 5 mg. at weekly intervals until optimal re-
tained. In patients 12 years of age and older, start 
daily; daily dosage may be raised in increments 
t weekly intervals until optimal response is ob-
Jthersome adverse reactions appear (e.g., insom-
exia), dosage should be reduced. 'Spansule' cap-
e used for once-a-day dosage wherever appropri-
blets or elixir, give first dose on awakening; addi-
; (1 or 2) at intervals of 4 to 6 hours. 
)ef»cit Disorder with Hyperactivity: Not recom-
children under 3 years of age. 
from 3 to 5 years of age, start with 2.5 mg. daily, 
elixir; daily dosage may be raised in increments 
t weekly intervals until optimal response is ob-
B years of age and older, start with 5 mg. once or 
daily dosage may be raised in increments of 5 
cly intervals until optimal response is obtained. 
»cases will it be necessary to exceed a total of 40 
ppr riflv 
Product;lnformation 
With*tablets or elixir, give first dose on awakening; addi-
tional doses (1 or'2) at intervals of 4 to 6 hours, r . : . >; 
Where possible, drug administration should be interrupted 
occasional))? to determine if there is a recurrence of beha r- / 
ioral symptoms sufficient to require continued therapy. •*'.> 
Exogenous Obesity: Usual dosage is one 10 or 15 mg. 'Span-
sule' capsule daily, taken in the morning, or up to 30 mg. 
daily by tablets or elixir, taken in divided doses of 5 to 10 mg. 
30 to 60 minutes before meals. Not recommended for this use 
in children under 12 years of age. 
How Supplied: 
'Spansule' capsules available: 5 mg., in bottles of 50; 10 mg. 
and 15 mg., in bottles of 50 and 500. 
Tablets, 5 mg., available in bottles of 100 and 1000. 
Elixir, 5 mg./5 ml., available in 16 fl. oz. (473 ml.) bottles. 
Shown in Product Identification Section, page 429 • T 
DX:L34 
DIBENZYLINE® Capsules $ 
[di-benz 'eh-leen ] 
(brand of phenoxybenzamine hydrochloride) 
Description: Each'Dibenzyline'capsule, with red cap and 
red body, is imprinted SKF and E33 and contains phenoxy-
benzamine hydrochloride, 10 mg. Inactive ingredients con-
sist of benzyl alcohol, cetylpyridinium chloride, D&C Red No. 
33, FD&C Red No. 3, FD&C Yellow No. 6, gelatin, lactose, 
sodium lauryl sulfate and trace amounts of other inactive 
ingredients. " - v -. 
'Dibenzyline' is N-(2-Chlorc>ethyl>.N-(lkmethyl-2-
phenoxyethyl) benzylamine hydrochloride. 
Phenoxybenzamine hydrochloride is a colorless, crystalline 
powder with a molecular weight of 340.3 which melts be-
tween 136" and 141*C. It is soluble in water, alcohol and chlo-
roform; insoluble in ether. / 
Actions:' Dibenzyline (phenoxybenzamine hydrochloride, 
SKAF) is a long-acting, adrenergic, a-receptor blocking agent 
which can produce and maintain "chemical sympathec-
tomy" by oral administration. It increases blood flow to the 
skin, mucosa and abdominal viscera, and lowers both supine 
and erect blood pressures. It has no effect on the parasympa-
thetic system. 
Indication: Phcyhromocytoma, to control episodes of 
hypertension and aweating. If tachycardia is excessive, it 
may be necessary to use a beta-blocking agent concomi-
tantly. 
Contraindications: Conditions where a fall in blood pres-
sure may be undesirable. 
Warning: 'Dibenzyline'-induced alpha -adrenergic blockade 
leaves be to-adrenergic receptors unopposed. Compounds 
that stimulate both types of receptors may therefore produce 
an exaggerated hypotensive response and tachycardia. 
Precautions: Phenoxybemamine hydrochloride has 
shown in vitro mutagenic activity in the Ames test and in 
the mouse lymphoma assay; it has not shown mutagenic 
activity in the micronucleua test in mice. In rats and mice 
repeated intraperitoneal administration of phenoxybenza-
mine hydrochloride resulted in peritoneal sarcomas. Chronic 
oral dosing in rats has produced malignant tumors of the 
gastrointestinal tract. 
The clinical significance of such test results is not estab-
lished. Nevertheless, these results should be given consider-
ation in determining the benefit-risk ratio as it applies to the 
individual patient 
Administer with caution in patients with marked cerebral or I 
coronary arteriosclerosis or renal damage. Adrenergic block- [ 
ing effect may aggravate symptoms of respiratory infec-
tions. 
Adverse Reactions: Nasal congestion, miosis, postural hy-
potension, tachycardia and inhibition of ejaculation may 
occur. These so-called "side effects" are actually evidence of 
adrenergic blockade and vary according to the degree of 
blockade. Furthermore, they tend to decrease as therapy is 
continued. Gastrointestinal irritation, drowsiness and fa-
tigue have also been reported. 
Dosage and Administration: The dosage should be ad-
justed to fit the needs of each patient. Small initial doses 
should be slowly increased until the desired effect is obtained 
or the side effects from blockade become troublesome. After 
each increase, the patient should be observed on that level be-
fore instituting another increase. The dosage should be car-
ried to a point where symptomatic relief and/or objective 
improvement are obtained, but not so high that the side ef-
fects from blockade become troublesome. 
Initially, 10 mg. of Dibenzyline (phenoxybenzamine hydro-
chloride, SK&F) twice a day. Dosage should be increased every 
other day, usually to 20 to 40 mg. two or three times a day, 
until an optimal dosage is obtained, as judged by blood pres-
sure control. 
Overdosage: Symptoms —These are largely the result of 
block of the sympathetic nervous system and of the circulat-
ing epinephrine. They may include postural hypotension 
resulting in dizziness or fainting; tachycardia, particularly 
nnstiirnl' vnmirincr- lprhnro-v cKrwlr Tror,tmor,f WVion I 
•1713 
consideration. In cases of mild overdosage, recumbent posi-
tion with legs elevated usually restores" cerebral circulation 
In the more severe cases, the usual measures to combat 
shock should be instituted. Usual pressor agents are not ef 
fective. Epinephrine is contraindicated because it stimulates 
both a and fi receptors; since a receptors are blocked, the net 
effect of epinephrine administration is vasodilation and a 
further drop in blood pressure (epinephrine reversal).. 
The patient may have to be kept flat for 24 hours or more in 
the case of overdose, as the effect of the drug is prolonged. 
Leg bandages and an' abdominal binder may shorten the 
period of disability. 
I.V. infusion of levarterenol bitartrate* may be used to com-
bat severe hypotensive reactions, because it stimulates a 
receptors primarily. Although Dibenzyline (phenoxybenza-
mine hydrochloride, SKAF) is an a adrenergic blocking agent; 
a sufficient dose of levarterenol bitartrate will overcome this 
effect. 
How Supplied: Dibenzyline (phenoxybenzamine hydro-
chloride, SK&F) capsules, 10 mg., in bottles of 100. 
•Available as Levophed® Bitartrate (brand of levarterenol 
bitartrate) from Winthrop Laboratories. 
Shown in Product Identification Section, page 429 
>I:L21 
DYAZIDE® Capsule* & 
[dye-uh-zide' ] 
ODyazide' is a product of SK&F Co., Carolina, P.R. 00630, 
Subsidiary of SmithKline Beckman Corporation, 
Philadelphia, Pa.) 
Warning: 
This fixed combination drug is not indicated for initial 
therapy of edema or hypertension. Edema or hyperten-
sion requires therapy titrated to the individual patient 
If the fixed combination represents the dosage so deter-
mined, its use may be more convenient in patient man-
agement. The treatment of hypertension and edema is 
not static, but must be reevaluated as coi t ions in 
each patient warrant 
Description: Each red and white 'Dyazide' capsule con-
tains 50 mg. of Dyremum® (brand of triamterene), a potassi-
um-sparing agent, and 25 mg. of hydrochlorothiazide. 
'Dyrenium' is 2, 4, 7-triamino-6-phenylpteridine. 
Hydrochlorothiazide is 6-chloro-3, 4-dihydro-2#-l, 2, 4-ben-
zothiadiazine-7-sulfonamide 1,1 -dioxide. 
At 50*C., triamterene is practically insoluble in water (less 
than 0.1%). It is soluble in formic acid, sparingly soluble in 
methoxyethanol, and very slightly soluble in alcohol. 
Hydrochlorothiazide is slightly soluble in water. It is soluble 
in dilute ammonia, dilute aqueous sodium hydroxide, and 
dimethylformamide. It is sparingly soluble in methanol. . 
Action: 'Dyazide' is a dmretic/antihypertensive drug prod-
uct that combines the natriuretic, hydrochlorothiazide, and 
the potassium-sparing natriuretic, triamterene, each "of 
which complements the action of the other. The hydrochloro1 
thiazide component blocks the reabsorption of sodium and 
chloride ions, and thereby increases the quantity of sodium 
traversing the distal tubule and the volume of water ex-
creted. A portion of the additional sodium presented to the 
distal tubule is exchanged there for potassium and hydrogen 
ions. With continued use of hydrochlorothiazide and deple-
tion of sodium, compensatory mechanisms tend to increase 
this exchange and may produce excessive loss of potassium, 
hydrogen and chloride ions. Hydrochlorothiazide also de-
creases the excretion of calcium and uric acid, may increase 
the excretion of iodide and may reduce glomerul y_ filtration 
rate. The exact mechanism of the antihyperteiul) <? effect of 
hydrochlorothiazide is not known. 
The triamterene component of 'Dyazide' exerts its diuretic 
effect on the distal renal tubule to inhibit the reabsorption of 
sodium in exchange for potassium and hydrogen ions. Its 
natriuretic activity is limited by the amount of sodium 
reaching its site of action. Although it blocks the increase in 
this exchange that is stimulated by mineralocorticoids 
(chiefly aldosterone) it is not a competitive antagonist of al-
dosterone and its activity can be demonstrated in adrenalec-
tomized rats and patients with Addison's disease. As a result 
the dose of triamterene required is not proportionally re-
lated to the level of mineralocorticoid activity, but is dictated 
by the response of the individual patient, and the kaliuretic 
effect of concomitantly administered drugs. By inhibiting 
the distal tubular exchange mechanism, triamterene main-
tains or increases the sodium excretion and reduces the ex-
cess loss of potassium, hydrogen, and chloride ions induced 
by hydrochlorothiazide. As with hydrochlorothiazide, 
triamterene may reduce glomerular filtration and renal 
plasma flow. Via this mechanism it may reduce uric acid 
excretion although it has no tubular effect on uric acid reab-
snrntinn or 'worptinn TnamtpronA Ancm nnt ofTo/** /»ol/»i»»m 
}f 30, 60, and 100 Also available, Rimac-
»oniazid USP) Dual Pack containing 60 Rimac-
and 30 INH 300-mg Tablets 
V, Kirby, W M..M, Sherns, J C, and Turck, 
usceptibihty testing by a standardized single 
im J Clin Path 45 493496, 1966 
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se tablets 
Ritalin is a white, odorless, fine crystalline 
ns of which are acid to litmus It is freely solu-
nacoiogy: Ritalin is a mild central nervous 
nt 
tion in man is not completely understood, but 
ably activates the brain stem arousal system 
iroduce its stimulant effect 
r specific evidence which clearly establishes 
\ whereby Ritalin produces its mental and 
cts in children, nor conclusive evidence re-
ese effects relate to the condition of the cen-
stem 
3R tablets is more slowly but as extensively 
he regular tablets Relative bioavailability of 
ompared to the Ritalin tablet, measured by 
retion of Ritalin major metabolite (a-phenyl-
etic acid) was 105% (49-168%) in children 
52%) in adults The time to peak rate in chil-
>urs (13-8 2 hours) for the SR tablets and 1 9 
ours) for the tablets An average of 67% of SR 
excreted in children as compared to 86% in 
L.filfQj^fllW^prr-'inii-lj known 
ain Dysfunction in Children) Other terms 
lescribe the behavioral syndrome below m-
netic Child Syndrome, Minimal Brain Dam-
Derebral Dysfunction, Minor Cerebral Dys-
ated as an integral part of a total treatment 
typically includes other remedial measures 
educational, social) for a stabilizing effect in 
i behavioral syndrome characterized by the 
p of developmentally inappropriate symp-
e to-severe distractibihty, short attention 
vity, emotional lability, and impulsivity The 
s syndrome should not be made with finality 
lptoms are only of comparatively recent on-
ng (soft) neurological signs, learning disabil-
^a\ EEG may or may not be present, and a 
tral nervous system dysfunction may or may 
sd 
tic Considerations 
, of this syndrome is unknown, and there is 
stic test Adequate diagnosis requires the use 
cal but of special psychological, educational, 
irces 
commonly reported include chronic history 
on span, distractibihty, emotional lability, 
d moderate-to-severe hyperactivity, minor 
ns and abnormal EEG Learning may or may 
I The diagnosis must be based upon a com 
i evaluation of the child and not solely on the 
or more of these characteristics 
is not indicated for all children with this 
ulants are not intended for use in the child 
mptoms secondary to environmental factors 
psychiatric disorders, including psychosis 
icational placement is essential and psycho-
ion is generally necessary When remedial 
are insufficient, the decision to prescribe 
\ition will depend upon the physician's as 
chronicity and severity of the child's symp-
IJTWpWiW^Ritalin is contraindicated also in 
to be hypersensitive to the drug, in patients 
ind in patients with motor tics or with a fam 
agnosis of Tourette's syndrome 
aim should not be used in children under six 
>ty and efficacy in this age group have not 
I 
weight gain, and/or height) has been reported with the long-
term use of stimulants in children Therefore, patients re-
quiring long-term therapy should be carefully monitored 
Ritalin should not be used for severe depression of either 
exogenous "or endogenous origin Clinical experience sug-
gests that in psychotic children, administration of Ritalin 
may exacerbate symptoms of behavior disturbance and 
thought disorder 
Ritalin should not be used for the prevention or treatment of 
normal fatigue states 
There is some clinical evidence that Ritalin may lower the 
convulsive threshold m patients with prior history of sei-
zures, with prior EEG abnormalities m absence of seizures, 
and, very rarely, in absence of history of seizures and no 
prior EEG evidence of seizures Safe concomitant use of anti-
convulsants and Ritalin has not been established In the 
presence of seizures, the drug should be discontinued 
Use cautiously in patients with hypertension Blood pressure 
should be monitored at appropriate intervals in all patients 
taking Ritalin, especially those with hypertension 
Symptoms of visual disturbances have been encountered m 
rare cases Difficulties with accommodation and blurring of 
vision have been reported 
Drug Interactions 
Ritalin may decrease the hypotensive effect of guanethidine 
Use cautiously with pressor agents and MAO inhibitors 
Human pharmacologic studies have shown that Ritalin may 
inhibit the metabolism of coumann anticoagulants, anticon-
vulsants (phenobarbital, diphenylhydantom, primidone), 
phenylbutazone, and tricyclic antidepressants (lmipramine, 
desipramine) Downward dosage adjustments of these drugs 
may be required when given concomitantly with Ritalin 
Usage in Pregnancy 
Adequate animal reproduction studies to establish safe use 
of Ritalin during pregnancy have not been conducted There-
fore, until more information is available, Ritalin should not 
be prescribed for women of childbearing age unless, in the 
opinion of the physician, the potential benefits outweigh the 
possible risks 
Drug Dependence 
Ritalin should be given cautiously to emotionally unsta-
ble patients, such as those with a history of drug depen-
dence or alcoholism, because such patients may in-
crease dosage on their own initiative 
Chronically abusive use can lead to marked tolerance 
and psychic dependence v-^h varying degrees of abnor 
mal behavior Frank psychotic episodes can occur, espe-
cially with parenteral abuse Careful supervision is re-
quired during drug withdrawal, since severe depression 
as well as the effects of chronic overactivity can be un 
masked Long term follow-up may be required because 
of the patient's basic personality disturbances 
Precaut ions: Patients with an element of agitation may 
react adversely, discontinue therapy if necessary 
Periodic CBC, differential, and platelet counts are advised 
during prolonged therapy 
Drug treatment is not indicated in all cases of this behavioral 
syndrome and should be considered only in light of the com 
plete history and evaluation of the child The decision to pre-
scribe Ritalin should depend on the physician's assessment 
of the chronicity and severity of the child's symptoms and 
their appropriateness for his/her age Prescription should 
not depend solely on the presence of one or more of the be-
havioral characteristics 
When these symptoms are associated with acute stress reac 
tions, treatment with Ritalin is usually not indicated 
Long-term effects of Ritalin in chddren have not been well 
established 
^NWHMri t aMiHMto Nervousness and insomnia are the 
most common adverse reactions but are usually controlled 
by reducing dosage and omitting the drug in the afternoon or 
evening Other reactions include hypersensitivity (including 
skin rash, urticaria, fever, arthralgia, exfoliative dermatitis, 
erythema multiforme with u:stopathological findings of 
necrotizing vasculitis, and thiuinbocytopenic purpura), ano-
rexia, nausea, dizziness mlxiljnf IJBPQ h n d i r h r . dyskinesia, 
drowsiness blood pressure and pulse changes, both up and 
down, tachycardia, anginaj*iWliPiPflfilllliWf**rxlominal 
pain, weight loss during prolonged therapy There have 
been rare reports of Tourette's syndrome Toxic psychosis 
has been reported Although a definite causal relationship 
has not been established, the following have been reported in 
patients taking this drug leukopenia and/or anemia, a few 
instances of scalp hair loss 
In children, loss of appetite, abdominal pain, weight loss 
during prolonged therapy, insomnia, and tachycardia may 
occur more frequently, however, any of the other adverse 
reactions listed above may also occur 
Dosage and Administration- Dosage should be individu-
alized according to the needs and responses of the patient 
^iciciauijr o u w t u iiuiiuues oeiore meais Averageaosageis 
20 to 30 mg daily Some patients may require 40 to 60 mg 
daily In others, 10 to 15 mg daily will be adequate Patients 
who are unable to sleep if medication is taken late in the day 
should take the last dose before 6 p m 
SR Tablets Ritalin SR Tablets have a duration of action of 
approximately 8 hours Therefore, Ritalin SR tablets may be 
used m place of Ritalin tablets when the 8 hour dosage of 
Ritalin SR corresponds to the titrated 8 hour dosage of Rita-
lin 
Children (6 years and over) 
Ritalin should be initiated in small doses, with gradual 
weekly increments Daily dosage above 60 mg is not recom-
mended 
If improvement is not observed after appropriate dosage 
adjustments over a one-month period, the drug should be 
discontinued 
Tablets Start with 5 mg twice daily (before breakfast and 
lunch) with gradual increments of 5 to 10 mg weekly 
SR Tablets Ritalin SR tablets have a duration of action of 
approximately 8 hours Therefore, Ritalin SR tablets may be 
used in place of Ritalin tablets when the 8 hour dosage of 
Ritalin SR corresponds to the titrated 8 hour dosage of Rita-
lin 
If paradoxical aggravation of symptoms or other adverse 
effects occur, reduce dosage, or, if necessary, discontinue the 
drug 
Ritalin should be periodically discontinued to assess the 
child's condition Improvement may be sustained when the 
drug is either temporarily or permanently discontinued 
Drug treatment should not and need not be indefinite and 
usually may be discontinued after puberty 
Overdosage: Signs and symptoms of acute overdosage, 
resulting principally from overstimulation of the central 
nervous system and from excessive sympathomimetic ef-
fects, may include the following vomiting, agitation, trem-
ors, hyperreflexia, muscle twitching, convulsions (may be 
followed by coma), euphoria, confusion, hallucinations, delir-
ium, sweating, flushing, headache, hyperpyrexia, tachycar-
dia, palpitations, cardiac arrhythmias, hypertension, mydri-
asis, and dryness of mucous membranes 
Treatment consists of appropriate supportive measures The 
patient must be protected against self injury and against 
external stimuli that would aggravate overstimulation al-
ready present If signs and symptoms are not too severe and 
the patient is conscious, gastric contents may be evacuated 
by induction of emesis or gastric lavage In the presence of 
severe intoxication, use a carefully titrated dosage of a short 
acting barbiturate before performing gastric lavage 
Intensive care must be provided to maintain adequate circu 
lation and respirator} exchange, external cooling proce-
dures may be required for hyperpyrexia 
Efficacy of peritoneal dialysis or extracorporeal hemodialy-
sis for Ritalin overdosage has not been established 
How Supplied-
Tablets 20 mg—round, pale yellow scored (imprinted CIBA 
34) 
Bottles of 100 NDC 0083-0034-30 
Bottles of 1000 NDC 0083-0034-40 
Tablets 10 mg —round, pale green, scored (imprinted CIBA 
3) 
Bottles of 100 NDC 0083-0003-30 
Bottles of 500 NDC 0083-0003-35 
Bottles of 1000 NDC 0083-0003-40 
Accu-Pak® Unit Dose (blister pack) 
Box of 100 (strips of 10) NDC 0083-0003-32 
Tablets 5 mg—round, yellow (imprinted CIBA 7) 
Bottles of 100 NDC 0083-0007-30 
Bottles of 500 NDC 0083-0007-35 
Bottles of 1000 NDC 0083-000740 
SR Tablets 20 mg—round, white, coated (imprinted CIBA 
16) 
Bottles of 100 NDC 0083-0016-30 
Note SR Tablets are color additi\e free 
Do not store above 86°F (30°C) Protect from moisture 
Dispense in tight, light resistant container (USP) 
C84-29 (Rev 6/84) 
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APPENDIX VI 
EVALUATION BY DR. JOSEPH PERRY 
July 29, 1986 
V , 
J. JOSEPH PERRY M.D, EA.C.C. 
CARDIOLOGY' 
COTTONWOOD MEDICAL TO^'ER 
5770 SOUTH 250 EAST, SUTi F 340-
MURRAY, UTAH 84107 
July 29, :'98'-) 
Shaun Howell 
Attorney at Law 
State Insurance Fund 
560 South 300 East 
P.O. Box 45420 
Salt Lake City, Utah 84145-0420 
RE: Dale W. Steward 
#86-05663 
Inj: 11-11-85 
Dear Counselor: 
I have evaluated all of the information sent to rne on this 
somewhat complicated case. 
It seems clear that Mr. Steward was not conscious when his 
rig swerved to the left and ran off coming to rest on top of the median wall 
without apparently overturning or coming to an abrupt stop as it would with 
a collision. Additionally on arrival in the Emergency Department there was 
no qross evidence of physical injury or trauma according to the emergency 
physician. Additionally, the photographs sent to me demonstrate very little 
trauma to the rig he was driving. Thus, I think trauma can be excluded 
with a reasonable degree of confidence in this case. 
Complicating the issue is the mention of narcolepsy in the 
medical record. The patient had given a history of sudden sleep attacks 
while driving and had been treated with amphetamines by his physician for 
several years prior to his demise. I find no studies in the record to 
document narcolepsy, thus this diagnosis is not secure in this individual. 
Of the two scenarios which may have occurred, that is falling 
asleep then suffering a cardiac arrest sometime after contacting the median 
wall, or having the cardiac arrest while driving, only the latter seems to 
have firm medical support. Had he suffered narcolepsy while driving he 
would have awakened when he left the road (I speak from experience) and 
there seemed to be no event which would have been of sufficient severity 
to cause his death. It is remotely possible that the shock and fear of 
waking up in the middle of a serious accident woul«I have been sufficient 
to engender the fatal cardiac arrhythmia, but this does not seem very 
probable. 
In terms of medical probability it is most likely that he ex-
perienced a fatal cardiac arrhythmia while driving, lost consciousness a few 
seconds later thus losing control of the vehicle and having the accident as 
reported. It is possible that his dextroamphetamine was related to his death 
because it may worsen arrhythmias in suseptible individuals. 
TELEPHONE (801) 266-3418 
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page 2 continued. 
An autopsy would have been supporting this diagnosis, but likely 
would not have confirmed it with an absolute degree of certainty^. .J suspeat it 
would have shown amphetamines present and coronary artery disease present.- 'At *»* 
this point in time exuming the body would not shed any light on -the "presence* * 
of amphetamine. It would, however, document the presence or absence of coronary 
artery disease. In the absence of drugs it is extremely unusual for cardiac 
arrest to occur in a person with normal coronary arteries. If the absence 
of coronary artery disease could be documented, then the scenario of striking 
the median wall, waking up and then suffering a fatal arrhythmia would become 
somewhat more plausible. Whether or not that has any legal significance is 
of course not within my area of expertise. 
In summary in terms of reasonable medical probability, the 
patient suffered a fatal arrhythmia while driving and the accident was simply 
the result of his death and subsequent loss of control of the vehicle. While 
other possibilities ^xist, they are far less likely0 To exume and perform 
a Dost-mortum examination of the body would *lter those probabilities to an 
extent, hut it is highly unlikely it would provide definitive answer. 
JL hone this has been helpful to you. 
Sincere 
J. Joseph Pe M.D. 
JJP/jv 
1*2 
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